Document:

EX-10.13

 Exhibit 10.13 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED 

BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

SUPPLY AGREEMENT 

THIS SUPPLY AGREEMENT (the “Agreement”) is entered into as
of 22 May 2020 (the “Effective Date”), by and between and thinXXS Microtechnology AG, a German corporation (“thX”); and TALIS BIOMEDICAL
CORPORATION, a Delaware corporation (“Talis”). 
 RECITALS 

WHEREAS, in connection with such expansion of capacity, Talis desires to have thX manufacture and supply, and thX
desires to so manufacture and supply, certain quantities of Products in accordance with the Specifications (each as defined below) for use with, or as a components of or related to certain proprietary device(s) of Talis and Talis’ Affiliates,
as more fully described herein; and 
 NOW, THEREFORE, in consideration of the foregoing and the
covenants and premises contained in this Agreement, the Parties agree as follows: 
 1. DEFINITIONS 

1.1 “Affiliate” shall mean, as to any Person, any other Person which directly or indirectly controls, is controlled by,
or is under common control with such Person. For purposes of the preceding definition, “control” shall mean beneficial ownership of more than fifty percent (50%) of the outstanding voting securities of a Person or the ability to elect a
majority of the board of directors or other managing authority of such Person or otherwise to control the direction of the management or policies of such Person (whether by contract or otherwise). [...***...] 

1.2 “Annual Forecast” shall have the meaning set forth in Section 3.3. 

1.3 “Annual Commitment PO” shall have the meaning set forth in Section 3.4(a).  

1.4 “Business Day” shall mean any weekday on which Talis is open for business. 

1.5 “Change” shall have the meaning set forth in Section 2.1. 

1.6 “Change of Control” shall mean, with respect to a Party, either of (a) any transaction or series of
related transactions resulting in a consolidation, merger or other business combination of such Party with or into any Third Party, or any transaction or series of related transactions as a result of which a Third Party directly or indirectly
acquires fifty percent (50%) or more of such Party’s voting power or otherwise obtains the ability to direct the management or policies of such Party, or (b) the sale to a Third Party of all or substantially all of such Party’s assets
in a single transaction or series of related transactions; provided that “Change of Control” shall exclude the sale of any class of shares and/or stock, or any other financial instrument, for the

  
 1. 

 
purpose of raising cash financing to fund any research and development by or on behalf of a Party, which financing could be from any source, including but not limited to venture capital, private
equity or any other corporation, or from private individuals. 
 1.7 “Change Request” shall have the meaning set
forth in Section 2.1. 
 1.8 “Chronic Supply Delay” shall mean with respect to agreed-upon delivery dates: (a)
[...***...] or more Supply Delays in any given [...***...]; (b) a Supply Delay in any [...***...] in a given [...***...] period; or (c) any failure by thX to deliver to Talis or its designees on time more than
[...***...] ([...***...]) of any Product ordered in accordance with this Agreement over any [...***...] period excluding any delay that is attributable to Talis or that is outside of the reasonable control of thX, provided further
that such failure is not caused by the following: (i) a Force Majeure Event; or (ii) Talis’s fault including, without limitation, Talis’s failure to supply raw materials to be supplied by Talis under Section 4.1. 

1.9 “Code” has the meaning set forth in Section 11.4. 

1.10 “Confidential Information” shall mean, subject to the exceptions set forth in Section 10.2, all information
regarding a Party’s technology, products or business that such Party discloses or makes available to the other Party under this Agreement, in each case, whether in oral, written, graphic, electronic or other form, including, in the case of
Talis, the Specifications. 
 1.11 “Consumables” shall mean
single-use cartridges for use with, e.g., the Talis-One system (or equivalent or successor systems) and as described in the Specifications. 

1.12 “Control” (including any variations such as “Controlled” and “Controlling”)
shall mean, with respect to a Party and any Information, Patent or other IP Rights, possession by the relevant Party of the ability (whether by ownership or license, other than pursuant to this Agreement) to grant the applicable license under this
Agreement under such Information, Patent or other IP Rights, without violating the terms of an agreement with a Third Party. 
 1.13
“Development Services Agreement” shall mean the agreement between the Parties and bearing such caption, between the Parties hereto, and dated as of 2 June 2017. 

1.14 “Epidemic Failure” shall have the meaning set forth in Section 9.5. 

1.15 “Equipment” shall mean [...***...] used to produce the Products; and additions to, substitutions for,
replacements of and accessions to any of the foregoing items, and attachments, parts (including spare parts) and accessories installed thereon or affixed thereto. For the sake of clarity Equipment shall not include Tools. 

1.16 “Exclusive Commitment Volume” shall have the meaning set forth in Section 3.2(a). 

1.17 “Extension Term” shall have the meaning set forth in Section 11.1. 

  
 2. 

 1.18 “Facility” means (i) initially, thX’s facility
located in [...***...]; and (ii) also, subsequently, such other mutually approved site of thX (or of an Affiliate of thX). 

1.19 “Force Majeure Event” shall have the meaning set forth in Section 13.10. 

1.20 “Information” shall mean information, ideas, inventions, discoveries, concepts, formulas, practices, procedures,
processes, methods, knowledge, know-how, trade secrets, technology, inventories, machines, techniques, development, designs, drawings, computer programs, skill, experience, documents, apparatus, results,
strategies, documentation and data, including analytical and quality control data, manufacturing data and descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, specifications (including Specification)
documents, material, compositions of matter, and the like, in written, electronic or other form, now known or hereafter developed, whether or not patentable. 

1.21 “IP Rights” shall mean any and all Information and all intellectual property rights in and with respect thereto,
including Patents, copyrights, trade secret rights, and applications for and registrations of the foregoing. 
 1.22 “Latent
Defect” shall mean a defect that causes a Product to not conform to the Specifications and/or to the Product Warranty, which defect is not discoverable upon reasonable physical inspection. 

1.23 “License Agreement” shall mean the agreement in the form set forth as Exhibit C hereto. 

1.24 “Losses” shall have the meaning set forth in Section 12.1. 

1.25 “MTP Tools” shall mean [...***...] which are owned by thX, but which can be used for several projects
(including for other customers). 
 1.26 “Party” or “Parties” shall have the meaning set forth in
the preamble. 
 1.27 “Patents” shall mean (a) patents,
re-examinations, reissues, renewals, extensions and term restorations, and foreign counterparts of any of the foregoing, and (b) pending applications for patents, including, without limitation,
provisional applications, continuations, continuations-in-part, requests for continued examination, divisional and substitute applications, including, without
limitation, inventors’ certificates, and foreign counterparts of any of the foregoing. 
 1.28 “Person”
shall mean any individual, partnership, limited liability company, corporation, association, joint stock company, trust, estate, joint venture, unincorporated organization, government or governmental body (or political subdivision thereof,
whether domestic or foreign) or any other entity of any kind. 
 1.29 “Plan” shall have the meaning set forth in
Section 11.5. 

  
 3. 

 1.30 “Processes” shall mean processes applied to generate and
assemble Products, as applicable to the relevant Product type. 
 1.31 “Product” shall mean, as applicable, any
product to be manufactured and supplied by thX to Talis and as set forth in EXHIBIT A as may be amended from time to time by Talis and thX. For clarity, the Products may include
(a) Consumables, (b) R&D Components, (c) new product offerings as may be mutually agreed upon by the parties in writing and incorporated in an amended Exhibit A as products to be manufactured and supplied by thX to Talis. 

1.32 “Product Defect” shall mean a defect that causes a Product to not conform to the Specifications and/or to the
Product Warranty. 
 1.33 “Product IP” shall mean IP Rights relating to the design and development of any Product,
or reading on any Product, inclusive of, but not limited to, Specifications, operating processes for each applicable Product, tolerances and surface finishes, drawings, materials, surface treatments, inspection techniques, and data regarding the use
of any Product, generated by thX or Talis separately or jointly as a result of activities conducted pursuant to this Agreement, but in all cases excluding the thX Background IP, thx Background Improvements, and thX Manufacturing and Process IP. 

1.34 “Product Warranty” shall have the meaning set forth in Section 9.2. 

1.35 “Production Line” means any production line for the production of Products established under this Agreement. 

1.36 “Production Tools” shall mean fixtures and mold tooling specific for production and qualification of the
R&D Components and/or Consumables and which are owned by ThX and paid for by Talis. 
 1.37 “Purchase Order”
shall have the meaning set forth in Section 3.4(b). 
 1.38 “Quality Agreement” shall have the meaning set
forth in Section 5.1. 
 1.39 “R&D Components” shall mean components and sub-assemblies of the Consumable considered as research & development deliverables intended to be used only for Talis internal research and development activities (e.g., allowing Talis to simplify assay
development and testing), and which are not for commercial use other than in connection with in-house design or (when and if applicable) in connection with in-house
manufacturing under the License Agreement, and including:  
 (a) [...***...] of varying volume and physical size that
are supplied to Talis or Talis’ Third Party supplier for [...***...]; and 
 (b) [...***...] of the consumable
(whether partially assembled or fully assembled) and in a form and configuration to be agreed by the Parties. 

  
 4. 

 1.40 “Reimbursement Authorization” shall have the meaning set forth
in Section 2.4(c). 
 1.41 “Rolling Monthly Forecast” shall have the meaning set forth in Section 3.3.

 1.42 “Second Production Line” shall have the meaning set forth in Section 2.3. 

1.43 “Specifications” shall mean the unique, version-controlled and comprehensive specifications for each specific
variant of each Product, the initial versions of which are attached hereto as part of EXHIBIT A, as the same may be amended from time to time by mutual written agreement of the Parties
in accordance with this Agreement and the Quality Agreement. 
 1.44 “statement of work” shall mean a statement of
work or similar document that references this Agreement and that, following its mutual execution by the Parties, will become part of and subject to this Agreement. 

1.45 “Supply Delay” shall mean any instance where the delivery of any quantity of Product to Talis pursuant to a
Purchase Order (or Annual Commitment PO) timely delivered and in accordance with this Agreement occurs on a date later than the specified delivery date set forth in the applicable Purchase Order (or Annual Commitment PO), excluding any delay that is
attributable to Talis or that is outside of the reasonable control of thX. For clarity, “Supply Delay” shall not include any delay in delivery to the extent caused by the following: (i) a Force Majeure Event; or (ii) Talis’
failure to supply raw materials to be supplied by Talis under Section 4.1. 
 1.46 “Talis Background IP”
shall mean all IP Rights that are either: (a) Controlled by Talis or its Affiliates on the Effective Date (other than as a result of thX disclosing or providing the same to Talis or to such Affiliate); or that is (b) developed or
acquired by Talis or its Affiliates during the Term in the ordinary course independently of any activities conducted pursuant to this Agreement. 

1.47 “Talis Indemnitees” shall have the meaning set forth in Section 12.2. 

1.48 “Talis IP” shall have the meaning set forth in Section 7.1. 

1.49 “Talis-Supplied Material” shall have the meaning set forth in Section 4.1(d). 

1.50 “Term” shall have the meaning set forth in Section 11.1. 

1.51 “Third Party” shall mean any entity other than Talis or thX or an Affiliate of Talis or thX. 

1.52 “Third Party Supplier” shall mean those Third Parties identified as the Third Party Supplier in
EXHIBIT A as the Third Party expected to provide certain raw materials or components in connection with the activities to be performed under this Agreement. 

1.53 “thX Background Improvements” shall mean all IP Rights that are developed as a result of activities conducted
pursuant to this Agreement and that constitute generally applicable improvements or modifications to the thX Background IP, in all cases, that (a) do not specifically 

  
 5. 

 
relate to any Product and (b) do not incorporate, and are not based on, any Confidential Information of Talis. 

1.54 “thX Background IP” shall mean all IP Rights that are either: (a) Controlled by thX or its Affiliates
on the Effective Date (other than as a result of Talis disclosing or providing the same to thX or to such Affiliate); or (b) developed or acquired, and Controlled, by thX or its Affiliates during the Term in the ordinary course independently of
any activities conducted pursuant to this Agreement, and (in each of (a) and (b) that is not thX Manufacturing and Process IP). 

1.55 “thX Indemnitees” shall have the meaning set forth in Section 12.1. 

1.56 “thX Manufacturing and Process IP” shall mean IP Rights owned by, developed by, or licensed to thX related
to manufacturing and processes (including any Process) related thereto, including without limitation [...***...] for the Product (but excluding, for clarity, the Specification), regardless of whether developed by or licensed to thX before or
after the Effective Date. 
 1.57 “Tool Inserts” shall mean product-specific and
design-specific parts of the Tools, and which are owned by thX and paid for by Talis. 
 1.58 “Tools” shall mean
tools and fixtures [...***...], including (a) MTP Tools, (b) Production Tools and (c) Tool Inserts (and any accessions, attachments, parts, accessories, substitutions, replacements and appurtenances to the foregoing), which
terms shall mean: 
 1.59 “Warranty Period” shall have the meaning set forth in Section 9.2. 

1.60 “Work Product” shall mean any and all written, electronic and physical output, including Products, designs and
studies that are conceived, created or otherwise reduced to practice by thX, and paid for by Talis, as a result of activities conducted by thX pursuant to this Agreement (but excluding thX Background IP, thX Background Improvements, and thX
Manufacturing and Process IP). 
 2. AGREEMENT OVERVIEW 

2.1 Development of Specification; Changes to Specification. Commencing promptly after the Effective Date, the Parties
shall continue their collaborative joint development of the Specification. When finalized, the Parties will incorporate the Specification as an Exhibit (or as part of an Exhibit) hereto. Talis and thX are jointly developing the Consumable, but for
clarity all Product IP will be solely owned by Talis, and thX agrees to assign and hereby assigns all Product IP to Talis. The Consumable incorporates certain parts that are covered by the Product Patents (as defined in the License Agreement) and
the manufacture of the Consumables by thX will include processes that utilize other IP Rights of thX, which also are incorporated in the scope of the License Agreement. Talis may request additions, deletions or amendments in respect of a
Specification (each a “Change”). Changes shall be requested in writing signed by an authorized representative of Talis (a “Change Request”). Neither Party shall have any obligations related to 

  
 6. 

 any proposed Change unless both Parties have agreed to the Change Request in writing in accordance with the
procedures set forth herein. thX’s acceptance of any Change Request may not be unreasonably withheld, subject to the Parties’ agreement on any reasonable and documented price increases or time line changes reasonably required to effectuate
the desired Change. As soon as reasonably possible after receipt of a Change Request, thX agrees to provide Talis with a written estimate of the cost and time line adjustments, if any, of the requested Changes. Upon the Parties’ mutual written
agreement to any Change Request, the Specification shall be deemed modified to reflect any such Changes. thX further agrees that it will facilitate changes to the Specifications that are necessary or appropriate in light of regulatory requirements
as provided by Talis in a Change Request. 
 2.2 Equipment and Tooling. Products will be manufactured using (i) Equipment
(a) provided by thX and owned and maintained by thX or (b) [...***...], in each case installed at a designated Facility; and (ii) Product-specific Tool Inserts and Production Tools manufactured or purchased by thX or [...***...],
and which shall be used only for the production of Talis Consumables (as more fully stated in Section 2.4), with the exception of [...***...], which Talis agrees may be used to produce parts for Third Parties. 

2.3 Establishment of Production Lines. The Parties will establish one or more Production Lines anticipated to facilitate the
supply of Product under this Agreement. To that end, promptly following the Effective Date the Parties shall agree on one or more statement(s) of work under this Agreement pursuant to which the Parties will design and establish [...***...]
initial semi-automated Production Lines and a [...***...] Production Line that is automated and for which [...***...]. The statement of work(s) will identify the type of line (e.g., automated, semi-automated), location of the Facility,
capacity of Consumables per year at the Facility, cost, Equipment, NRE rate, plan and deliverables. The establishment of each Production Line will be subject to standard quality procedures, including those set forth in the Quality Agreement, and the
terms of the applicable statement(s) of work hereunder. For clarity, Talis is responsible for registration and regulatory conformity of the Talis product into which any Consumable is intended to be incorporated, as well as for the communication with
the regulatory authorities in the different countries as necessary in respect of such Talis product (though thX will provide reasonable assistance with the foregoing at no cost). For the sake of clarity, if any process validation is required, thX
may charge [...***...] for that assistance in accordance with the applicable statement of work. If Talis’ volume requirements exceed the capacity provided in the [...***...] Production Lines, Talis shall have the option, and thX
hereby grants Talis such option, to have a [...***...] or any subsequent Production Line established at the thX initial Facility or another IDEX site. Any such [...***...] or subsequent Production Line will be established pursuant to
commercially reasonable terms under a statement of work, provided that [...***...] shall bear the cost of such establishment, unless otherwise agreed therein. 

2.4 Purchase and Ownership of Tools and Equipment. 

(a) Until the semi-automated Production Line is available to Talis, (i) Talis shall have no specific Product purchase obligations
(and Sections 3.3 and 3.4(a) shall not apply) and (ii) thX shall continue to produce and make available Products at the manual pricing level set forth in Exhibit A hereto. For clarity, unless otherwise stated in a statement of work,
[...***...] 

  
 7. 

 
[...***...] all Tools and all Equipment for use in connection with manufacturing at [...***...] sole cost and expense. 

(b) [...***...] shall purchase directly, in each case from a mutually agreed supplier (or one identified pursuant to the relevant
statement of work) Equipment and Tools to be used in the Production Lines, unless otherwise indicated in a statement of work; in each such case, the relevant Equipment and Tools shall be owned by thX but shall be subject to this Section 2.4.
Product-specific Tools will be used solely for production of Products, unless otherwise agreed by Talis in writing. For the avoidance of doubt, all Tools produced by thX and paid for by [...***...] hereunder or under the Development Services
Agreement (other than [...***...], as defined herein) are subject to this paragraph and to the relevant statement of work. 

(c) Talis agrees to pay the mutually agreed upon amount provided by thX to Talis, the amount of which shall be set in accordance with
the relevant statement of work, for Tools, Production Tools, and Tool Inserts. Any amounts payable under this Section shall be invoiced by thX on [...***...] and Talis shall pay undisputed amounts so invoiced in U.S. Dollars net
[...***...] after receipt of the applicable invoice. 
 (d) All Equipment and Tools that are supplied by or paid for by
[...***...] (as well as other tangible property furnished by or through [...***...]), and any other software incorporated into such Equipment that [...***...] paid to develop pursuant to a statement of work issued hereunder shall
be owned by [...***...], but shall be subject to the provisions of this Section 2.4. [...***...] shall not commingle such property with the property of [...***...] or with that of a Person and shall not move any such property
from the relevant Facility without prior written approval by [...***...]. To the fullest extent permitted by law, [...***...] shall not allow any lien or encumbrance to be imposed on or attach to such property. [...***...] shall,
[...***...], insure all such Property with full and extended coverage for all damage and losses, for its full replacement value, as such value is reasonably determined by [...***...] and communicated in writing to [...***...]. All
replacements of, and all replacement parts, additions, improvements, and accessories for, such property will automatically become subject to this Section 2.4 upon their incorporation into or attachment to such property. 

(e) [...***...] will be responsible for maintaining, repairing and replacing the property described above [...***...]), and
will provide [...***...] with access to all maintenance records and certificate of insurance, including any insurance records evidencing the coverage for the applicable property in the amounts as set forth in Section 2.4(d). For
Production Tools and Tool Inserts, the guaranteed number of shots is [...***...] for the tool frame and [...***...] for each insert. To reduce the risk of loss of supply, Talis may order backup Tool Inserts from thX. 

(f) Upon termination of this Agreement by Talis pursuant to Section 11.2(a) hereof, [...***...] shall assign all right,
title and interest in and to the property that [...***...] purchased and is described in Sections 2.4(a), (b) and (d) to [...***...]; upon the expiration or termination of this Agreement for any other reason, or upon the end of the
normal life of any of such property, [...***...] shall destroy such property and certify its destruction to [...***...] in accordance with Section 11.2 hereof. 

  
 8. 

 3. SALE AND PURCHASE OF
PRODUCTS 
 3.1 Purchase and Supply Agreement. Subject to the terms and conditions of this Agreement, thX
agrees to supply, and Talis agrees to purchase, such quantities of Products as may be set forth in Purchase Orders (or Annual Commitment PO) placed by Talis in accordance with the provisions of Section 3.4. 

3.2 Contingent Exclusivity. 

(a) Subject to thX’s ability to timely provide Consumables in line with the Specifications, the Quality Agreement and the other
requirements of the Agreement, thX shall have the right to be the exclusive supplier for the Consumables for up to an aggregate volume of [...***...] Consumables on [...***...] basis (“Exclusive Commitment Volume”),
provided that, for clarity, the Exclusive Commitment Volume is not a purchase commitment. 
 (b) To the extent that Talis is granted
a license to make or have made Licensed Products (as defined in the License Agreement) pursuant to License Triggers (ii) or (iii) (as defined in the License Agreement), any such Licensed Products that are
single-use cartridges for use with, e.g., the Talis-One system (or equivalent or successor systems), and that are made by or for Talis under such license, shall be
credited towards the Exclusive Commitment Volume set forth in Section 3.2(a) in the applicable [...***...]. 
 3.3
Forecasts. On [...***...], or another date otherwise agreed to by the Parties, of each calendar year during the Term, assuming that the semi-automated Production Line has been fully activated, commencing on the [...***...]
prior to the calendar year in which Talis anticipates that it will first require Products under this Agreement, Talis shall specify its forecasted requirements of Products (quantity and type) by providing to thX a written forecast setting forth the
total number of Products (by Product type) that Talis anticipates purchasing during each month of following calendar year (i.e. the next to occur January – December) (each such forecast, an “Annual Forecast”). On the first
Business Day of each month during the Term following the delivery of the initial Annual Forecast, Talis shall provide thX with an updated [...***...] rolling forecast of its anticipated orders of Products (by Product type) to be placed during
each month of the rolling [...***...] period (with such period commencing on the first month of initial Annual Forecast) (each, a “Rolling Monthly Forecast”). For clarity the Rolling Monthly Forecast delivered in
[...***...] of each calendar year shall be deemed the Annual Forecast on which Talis’ annual purchase commitments will be calculated for the following calendar year, as described in additional detail in Section 3.4(a). Without
limiting thX’s obligations hereunder, thX shall keep Talis regularly informed of its manufacturing capacity for Consumables (and other Products), and shall promptly notify Talis if at any time thX anticipates that it will not be able to
manufacture and supply to Talis the amount of Consumables (or other Products) set forth in any Annual Forecast or Rolling Monthly Forecast, and shall provide Talis its best estimate of the timing and quantities of Consumables and/or other Products
that it will be able to supply. Talis shall have the right to [...***...]. As set forth in additional detail in Section 3.4, Talis shall order Products through the submission of (a) a blanket annual purchase order setting forth
Talis’ initial annual purchase commitment (and thX’s 

  
 9. 

 corresponding supply commitments) for the next calendar year, and (b) quarterly purchase orders setting
forth Talis’ additional commitment (and thX’s corresponding additional supply commitments) for amounts of Product in excess of the quantities ordered in the blanket purchase order described in (a) above. For clarity, other than as set
forth in Section 3.4, each Rolling Monthly Forecast shall be non-binding, but shall reflect Talis’ good faith expectation (at the time of submitting the applicable forecast) of the quantity of
Products (by Product type) it expects to order during the applicable [...***...] period. 
 3.4 Purchase Orders. 

(a) On [...***...], or another date otherwise agreed to by the Parties, of each calendar year during the Term following the
delivery of the initial Annual Forecast, Talis will issue a blanket purchase order for (i) [...***...]% of the quantity of Product (by Product type) identified in the first [...***...] months of the then-current Annual Forecast (i.e.
[...***...] of the following calendar year), including the expected delivery dates and any special shipping, storage or other instructions therefor, (ii) [...***...]% of the quantity of Product (by Product type) identified in the
following [...***...] months of such Annual Forecast (i.e. [...***...]); and (iii) [...***...]% of the quantity of Product (by Product type) identified in each of the last [...***...] months of such Annual Forecast
(i.e. [...***...]) (each such annual purchase order, an “Annual Commitment PO”). For clarity, subject to the terms of this Agreement, the Annual Commitment PO constitutes a binding commitment on Talis to purchase and on
thX to manufacture and supply the applicable quantities of Products set forth in such Annual Commitment PO. 
 (b) In addition to the
Annual Commitment PO, Talis shall place quarterly purchase orders for its additional Product requirements (if any) by submitting to thX written purchase orders using Talis’ standard purchase order form on or around each of [...***...],
[...***...] and [...***...] during the Term, which shall (a) specify any additional quantity of Products (by Product type) that it requires in [...***...] of the [...***...], to the extent that its requirements are in
excess of the quantities set forth in the Annual Commitment PO for any corresponding month, (b) provide a delivery dates for any such Product consistent with the applicable order lead time for the relevant Product stated in Exhibit A, and
(c) include any special shipping, storage or other instructions applicable to such order (each a “Purchase Order”). For clarity, and by way of example, a Purchase Order delivered by Talis on [...***...] of a given
calendar year would set forth the quantities of Product required by Talis for each of the following [...***...], to the extent such requirements were in excess of quantity ordered pursuant to the relevant Annual Commitment PO. 

(c) thX shall promptly (in all cases within [...***...]) send its acceptance of each Purchase Order (or Annual Commitment PO) to
Talis in writing, which acceptance will be a binding obligation on thX to fulfill such Purchase Order (or Annual Commitment PO) and on Talis to purchase those Products in advance of the desired delivery dates specified therein, as applicable;
provided, however, that thX shall not be required to fulfil any portion of any Purchase Order corresponding to (i) a quantity of Product (by Product type) greater than the applicable quantity(ies) set forth for the corresponding month of the
then-current Rolling Monthly Forecast, or (ii) for any Product(s) ordered inside of the applicable order lead time set forth on EXHIBIT A for such Product, [...***...]. thX shall notify Talis whether or not thX will
be able to fulfill the excess portion of any Purchase Order (or part thereof) 

  
 10. 

 
and the expected delivery date for fulfillment. If thX cannot fulfil a Purchase Order or Annual Commitment PO (or any portion of the foregoing) for any reason, then, thX shall immediately notify
Talis and (A) the project managers of each Party will meet and discuss the reason for the same and make any mutually agreed modifications required to facilitate such manufacture and supply; and (B) thX will confirm to Talis whether and to
what extent it can meet the desired delivery date for the excess quantities or reduced lead time Product ordered (as may be adjusted by the mutual agreement of the project managers). For any accepted Purchase Order (or Annual Commitment PO), thX
shall notify Talis within [...***...] if there are any issues that may prevent thX from meeting the desired delivery date or quantity of Products. Any Purchase Order (or Annual Commitment PO) submitted by Talis to thX shall be governed by the
terms contained herein. The Parties hereby agree that any term or condition in any Purchase Order, Annual Commitment PO, confirmation or other document furnished by Talis or thX that is in any way inconsistent with these terms and conditions shall
be void and of no effect. If Talis cancels any Purchase Order thX will use [...***...] to mitigate any attendant costs. 
 3.5
Delivery. All Products delivered pursuant to the terms of this Agreement will be suitably packaged and delivered in accordance with the Specifications and applicable laws, rules and regulations, and the terms of the Quality Agreement, but in
any event, in a manner designed to ensure safe shipment, to the address(es) specified in Talis’ purchase orders. thX shall use [...***...] efforts to deliver Products on the dates and in the quantities specified in Talis’ Purchase
Orders (or any Annual Commitment PO). Unless otherwise agreed by the Parties, each shipment will be delivered [...***...]. For Product shipments that are packaged by thX according to agreed upon Specifications, [...***...]. Together with
shipment of any Products, thX shall provide to Talis a document certifying that such Products were manufactured in accordance with the Product Warranty, and any other documentation otherwise required by the Quality Agreement. 

3.6 Acceptance and Rejection. Talis may reject any Product that has a Product Defect or that otherwise does not conform
to Talis’ purchase order or to the Product Warranty, or that fail the acceptance criteria (if any) specified for that Product in Exhibit A. In order to reject a Product, Talis must give written notice of rejection to thX within
[...***...] after receipt of such Product or, in the case of a Latent Defect, within [...***...] after Talis becomes aware of such Latent Defect, which notice shall specify the reason for rejection. If no such notice of rejection is
received within the relevant time frame, the shipment of Product shall be deemed to have been accepted, provided that, notwithstanding any acceptance or deemed acceptance of Product, the Product Warranty shall continue to cover the Product. Any
Product rejected by Talis will be subject to the same provisions as those applicable to a breach of the Product Warranty. Talis will maintain records of Product failures in Talis’ customer facilities and inform thX in accordance with the
requirements of the Quality Agreement. 
 4. MANUFACTURE 

4.1 Raw Materials; Third Party Supplier Components; Safety Stock. 

(a) [...***...] will source and pay for all Raw Materials as defined in Exhibit A hereto. All Raw Materials will comply with
approved and issued Specifications and be fully traceable to 

  
 11. 

 
source supply. thX will inspect and store all Raw Materials in accordance with standards agreed with Talis and the Quality Agreement. Raw Material vendors [...***...]. Raw Material
production must comply with ISO 13485 or ISO 9001 requirements including sourcing, traceability, and storage at thX manufacturing location. For the sake of clarity, the Raw Material vendors selected and used for the approved prototype shall be the
same vendors used in production if not otherwise jointly agreed on by the Parties. For clarity, [...***...]. 
 (b) To the
extent required to meet supply and lead-time requirements in Exhibit A, Talis will provide Third Party Supplier parts required to fulfil the Consumable manufacturing and delivery in advance and maintain an inventory level that the Parties
mutually agreed upon, provided that Talis will not provide any Third Party Supplier parts in excess of the amounts required for the anticipated production to occur in the next calendar quarter in the most recent Rolling Monthly Forecast (unless
otherwise agreed in writing). Talis shall place orders on the basis of frame contracts or supply agreements with the Third Party Suppliers and manage the supply chain. In certain key cases, [...***...], thX may enter into a communication
protocol with Third Party Suppliers providing materials or sub-assemblies for the Consumables, subject to (i) related terms being mutually agreed on between the each of Talis, thX and such Third Party
Supplier, and establishing appropriate protocols as between the Parties for dealing with Third Party Suppliers (and deciding whether such protocols such be in the body of the Agreement or elsewhere). In addition, as the reasonably requested by
either Party in light of ongoing and changing relationships with Third Party Suppliers, the Parties will meet in good faith to update any then-current protocols to address such changed circumstances in dealing with any Third Party Suppliers. The
quality inspection routines required to approve the incoming inspection of the Third Party Supplier components shall be defined in the Quality Agreement attached as Exhibit B, hereto. [...***...] will bear the costs related to the
implementation and execution of incoming inspections of Third Party Supplier components. 
 (c) At all times during the Term, thX
shall at its own cost and expense maintain an amount of inventory of all necessary components and materials (“Safety Stock”) in quantities necessary to fulfill the manufacture and supply of Products set forth in the next to occur
[...***...] in the most recent [...***...] forecast, or in other amounts as agreed by the Parties in writing] (the “Minimum Safety Stock Level”). If [...***...] determines that the Minimum Safety Stock Level should
be, and reasonably can be increased, taking into consideration [...***...] and other factors, such as general availability of raw materials, which may include long-lead time components, and equipment availability, [...***...]. thX shall
maintain the Safety Stock for the sole benefit of Talis. This Safety Stock shall remain separate and distinct from inventory held at the Facility and shall be stored by thX. thX will use Safety Stock to supply Products ordered by Talis hereunder and
will maintain the appropriate level of Safety Stock by promptly replenishing that quantity of Products used in such supply. thX will manage Safety Stock on a “first in, first out” basis to fulfill Talis’ purchase orders on a routine
basis. In the event Safety Stock levels drop below the Minimum Safety Stock Level, thX shall (i) immediately notify Talis; and (ii) use [...***...] to replenish its Safety Stock to the Minimum Safety Stock Level

  
 12. 

 
within in a reasonable period of time under the circumstances. In the event of a Safety Stock failure, thX shall (i) conduct a root cause analysis to identify the cause of the Safety Stock
failure and provide to Talis a written report detailing the cause of the Safety Stock failure, and (ii) deliver a corrective action plan to Talis which plan shall identify the steps thX will take to remedy the Safety Stock failure and mitigate
the likelihood of reoccurrence, including a schedule for implementation of the plan. 
 (d) If this Agreement or any Purchase Order
(or Annual Commitment PO) provides for Talis to supply any material to thX, including materials or components provided via Third Party Suppliers (“Talis-Supplied Material”), thX shall store such Talis-Supplied Material according to
established storage conditions for the material or parts (as set forth in the Quality Agreement or otherwise notified in writing by Talis or by such Third Party Supplier) and [...***...], provided that, where unique storage conditions are
necessary for the applicable Talis-Supplied Material, the Parties would agree on [...***...]. thX agrees (a) to account for all Talis-Supplied Materials, (b) not to provide Talis-Supplied Materials to any Third Party (including
permitted subcontractors) without the express prior written consent of Talis, (c) not to use Talis-Supplied Materials for any purpose other than conducting the development and/or manufacturing activities under the applicable purchase order, and
(d) to destroy or return to Talis all unused quantities of Talis-Supplied Materials according to Talis’ written directions. Further, thX agrees not to analyze, characterize, modify or reverse engineer any Talis-Supplied Materials or take
any action to determine the structure or composition of any Talis-Supplied Materials unless and to the extent required under the applicable purchase order. Talis will at all times retain title to and ownership of the Talis-Supplied Materials and any
related work in process at each and every stage of the manufacturing process. thX will provide within the Facility an area or areas where the Talis-Supplied Materials, Products, and any work in process are segregated and stored in accordance with
the Specifications, and in such a way as to be able at all times to clearly distinguish the same from products and materials belonging to thX, or held by it for a Third Party’s account. thX will at all times take such measures as are required
to protect the Talis-Supplied Materials, Products, and any work in process from risk of loss or damage at all stages of the manufacturing process. thX will ensure that Talis-Supplied Materials, Products, and any work in process are free and clear of
any liens or encumbrances. thX will immediately notify Talis if at any time it believes any Products or Talis-Supplied Materials have been damaged, lost or stolen. Talis agrees to maintain safety stock of Talis-Supplied Material in accordance with
the same levels required under Section 4.1 (c) for Safety Stock and Minimum Safety Stock. 
 4.2 Manufacture. 

(a) Compliance. thX shall manufacture and supply Products in accordance with the Specifications and all applicable laws, rules
and regulations. thX shall promptly notify Talis of any failure of the Products to conform to the foregoing and will provide any additional information regarding such non-conforming Products as may reasonably
be requested by Talis. In the event Talis notifies thX of any new manufacturing requirements or Specifications required by Talis, any regulatory agency, or of any other new legal requirements, the Parties shall promptly confer with each other with
respect to the best means to comply with such requirements and [...***...]. Upon Talis’ written request, thX shall supply Talis with copies of thX’s manufacturing records for the purposes of assuring Product quality. thX represents
and warrants to Talis that it has, and will maintain during 

  
 13. 

 
the Term, all government permits, including, without limitation, health, safety and environmental permits, necessary for the conduct of the actions and procedures that it undertakes pursuant to
this Agreement. 
 (b) Use of Approved Facilities. Manufacture of Products shall be performed only in the approved
Facility(ies). The Parties agree that thX’s [...***...] locations are approved Facilities. Change of a Facility location following initial approval, or addition of a new Facility, must be approved by Talis with such approval not
unreasonably withheld (withholding approval based on regulatory concerns shall be deemed reasonable, however). Talis will have the right to inspect only the portion of the relevant Facility that is dedicated to the production of the Product from
time to time in its reasonable discretion and upon reasonable notice. The inspection does not include the review of individual processes or steps, unless required for regulatory compliance. 

(c) Subcontracting. With the exception of non-Product specific subcontractors for which
Talis does not need to provide written consent, thX covenants and agrees that it shall not utilize any subcontractors (other than its Affiliates) to perform any of its duties and obligations hereunder without first obtaining the prior written
consent of Talis, which consent shall not be unreasonably withheld. thX covenants, acknowledges and agrees that it shall be responsible for all acts and omissions of approved subcontractors or Affiliates hereunder. 

(d) Confidential Treatment and Certain Disclosures. Without limiting thX’s confidentiality obligations and restrictions on
use of Tools and certain Equipment, Talis is aware and acknowledges that thX uses its Facility to manufacture non-Talis products. thX will not, without permission from Talis, show the Talis manufacturing line,
processes or proprietary technologies to any Third Parties and, if possible, will place the manufacturing line(s) in an isolated location within whichever Facility the line is established. Talis agrees that thX may disclose the scope and nature of
thX activities covered by the Agreement to all regulators/competent authorities/notified bodies as required by law, and subject to advance notice to Talis. 

4.3 Testing. Products supplied hereunder will conform to the Specifications. thX shall perform quality control testing and
quality oversight on Products to be delivered to Talis or its designee hereunder to ensure that the Products so delivered are in accordance with the Specifications or as otherwise required in accordance with the Quality Agreement. The Parties agree
that, should Talis wish to implement any amendment to the quality control testing and quality oversight on Products, Talis shall provide written notice thereof to thX for thX’s review and approval, which approval shall not be unreasonably
withheld, delayed or conditioned. The Parties acknowledge that as the Specifications are refined and modified, as the Parties gain experience with the manufacture, testing and use of the Products and as the development stage of the Product
progresses, then there may be a need for additional or modified quality control testing and quality oversight. Accordingly, Talis and thX agree to negotiate in good faith to modify any existing quality control testing and quality oversight in light
of any Specification change or otherwise from time to time as the Parties’ experience with the manufacture, testing and use of the Products warrants. The Parties agree to [...***...] of developing and implementing revised procedures. 

  
 14. 

 4.4 Non-U.S. Legal Requirements. If
Products are to be manufactured in a Facility in any jurisdiction outside of the United States, thX is solely responsible for such manufacture being performed in accordance with any applicable laws, rules or regulations of governmental authorities
in such jurisdiction. Without limiting the foregoing, each Party shall promptly notify the other of any new instructions or changes to Specifications required by any such governmental authority of which it becomes aware, and the Parties shall confer
with each other with respect to the best means to comply with such requirements. thX covenants and agrees that it shall comply with all applicable import-export laws, rules and regulations, including, without limitation, provision of Harmonized
Tariff Schedule (HTS) codes and Export Control Classification Number (ECCN) codes for all Products so shipped. 
 5. QUALITY 

5.1 Quality Agreement. The Parties shall, reasonably prior to the manufacture of any Product by thX, prepare and enter into a
reasonable and customary quality agreement (the “Quality Agreement”), substantially in the form attached hereto as EXHIBIT B. The Quality Agreement shall include the
matters referenced in other Sections of this Agreement, as well as provisions with respect to, among other things, Specifications in respect of product; validation; raw materials; inspection; Equipment; documentation requirements; nonconforming
product and deviations from manufacturing process; nonconforming incoming materials; yield; process validation; quality audit; records retention; design control; corrective and preventive action; and quality assurance obligations of the Parties for
the Product. Upon completion and execution by the Parties, the Quality Agreement shall be made a part of and incorporated into this Agreement. For clarity, any breach of the Quality Agreement will be deemed a breach of this Agreement. In the event
of a conflict between any of the provisions of the Supply Agreement and this Quality Agreement with respect to any commercial matters including allocation of risk liability and financial responsibility, the provisions of the Supply Agreement shall
govern. 
 5.2 Additional Quality Obligations. In addition to the quality-related matters described in Section 5.1, the
Parties will adhere to the following quality-related procedures and requirements, to the extent not otherwise agreed in the Quality Agreement: 

(a) The Consumables will be manufactured according to requirements of ISO 13485. Any changes in ISO13485 certification status of either
Party shall be communicated to the other Party as soon as practically possible, and in the case that any ISO13485 audit reveals any non-compliance relevant to this Agreement or any performance hereunder, such
communication shall include plans for timely corrective actions. For clarity, to the extent they are inconsistent with ISO 13485, the requirements of 21 CFR Part 820 and In Vitro Diagnostic device directive 98/79/EC or the successor In Vitro
Diagnostic Regulation will continue to apply to the manufacture of Products hereunder. 
 (b) As may be set forth in additional
detail in the Quality Agreement, each Party shall share relevant post-market surveillance and vigilance information generated or obtained in connection with this Agreement with the other Party. To that end, each Party shall endeavour to collaborate
in a timely manner and in good faith in order to: (i) address complaints, (ii) conduct investigations, (iii) facilitate recalls, (iv) undertake and/or monitor corrective/preventive actions, (v) meet regulatory reporting
requirements; (vi) manage import/export of product and onward 

  
 15. 

 
distribution, (vii) address alternative delivery addresses for specific shipments and (viii) appropriately address any other mandated regulatory actions, in each case, in accordance
with the roles and responsibilities of the Parties set forth in the Quality Agreement. 
 (c) Each Party shall share complaints
received relating to reportable or adverse incidents where the Consumable may be involved of which such Party is aware with the other Party. 

(d) Each Party shall collaborate to respond appropriately and within defined timescales under this Agreement or the Quality Agreement
to any matters described in this Section 5.2 to facilitate effective responses in relation to such matters. 
 (e) thX will
maintain at the thX premises (i) Standard ThinXXS Operating Procedures (SOP) and (ii) Device History Records (DHR), which shall remain in the thX premises unless otherwise agreed. In addition, if the foregoing documents (or
similar or ancillary documents to the foregoing documents) are requested by any regulatory authorities, thX will either provide (or cause to be provided) Talis with such documents or, if appropriate, otherwise deliver (or cause to be delivered) such
documents directly on behalf of Talis and provide written notice to Talis of such completed delivery. 
 (f) thX will be required to
seek Talis approval in advance for changes made to any manufacturing processes and parts that are used in the production of Talis products, for any requested changes to the Specifications (in accordance with the terms hereof) and any other material
changes in the raw materials, equipment, processes or procedures used to manufacture Product. With respect to any Minor changes, thX will notify Talis following the implementation and prior to release of any batch manufactured with such change.
“Minor changes” are changes that have no impact to quality, specifications or regulatory purposes. 
 (g) thX
will provide Talis with the following reports on demand on the following, (i) root cause analysis (“RCA”) for nonconforming product and incoming material, (ii) status of any in process CAPA’s, (iii) documentation
of compliance with quality system, (iv) results of thX QC testing as specified in the Quality Agreement (v) any other information outlined and agreed to in the Quality agreement, in each case (i)-(v), in a form and with substance
reasonably acceptable to Talis and set forth in the Quality Agreement.  
 (h) thX also will provide Talis with the
following reports, as applicable: (i) results of QC testing and COC for materials/components provided by Third Party Suppliers and (ii) RCA for nonconforming Product, in each case (i)-(ii), in a form and with substance reasonably
acceptable to Talis and set forth in the Quality Agreement. 
 6. REGULATORY 

6.1 Regulatory Compliance. thX shall comply with all regulatory requirements with respect to Product imposed by applicable law
upon thX as the manufacturer of Product and that are provided by Talis in commercially reasonable detail that will allow thX to comply. thX shall, on a timely basis, provide Talis with information in thX’s possession relevant to its role as the
manufacturer of Product that is reasonably necessary for and relevant to Talis’ obligations hereunder in complying with such regulatory requirements. thX will provide to Talis such 

  
 16. 

 
documentation, data and other information relating to Product as Talis may reasonably require for submission to governmental authorities. thX shall also provide, upon reasonable request by Talis,
information concerning its production processes and quality control procedures with respect to Product.  
 6.2 Recalls.
In the event Talis shall be required or requested by any governmental authority or shall voluntarily decide in good faith, after conducting an analysis to confirm that one is warranted under the circumstances, to recall any Product, Talis shall,
as between the Parties, have the sole authority to conduct and/or coordinate such recall. thX shall use [...***...] efforts to timely cooperate with Talis in the investigation and conduct of such recall. If a recall arises solely out of a
Latent Defect during the warranty period or due to thX’s willful misconduct, then thX shall repair or replace Product at its cost or reimburse Talis for the purchase price paid by Talis to thX for such Product and reimburse Talis for the
following direct and reasonable and necessary costs and expenses actually incurred by Talis in connection with the recall limited to (a) investigation and analysis, (b) shipping, (c) communication of the recall, as well as
(d) providing a workaround solution, if necessary. If a recall is due to any reason other than one that arises [...***...] or [...***...] shall pay all of the costs and expenses of the recall. 

6.3 Regulatory Inspections. thX agrees to inform Talis within [...***...] of notification of any regulatory inquiry,
communication or inspection, which directly or indirectly relates to the manufacture of Product. In the event thX receives a notice of inspection or an inspection visit by any governmental authority which involves Product or could impact thX’s
ability to produce Product, thX shall notify Talis within [...***...] of notification by such governmental authority. Talis, at its option, shall have the right to have its representatives present at any such inspection by a governmental
authority. In the event there are written observations (or any other written communication) by a governmental authority that involve Product or could impact thX’s ability to produce Product, or any proposed written response by thX to any such
inspection, Talis shall be informed within [...***...] and be provided with copies of all documentation within [...***...], and shall have a reasonable opportunity to review and comment on the proposed response, and thX shall consider
Talis’ comments in good faith. 
 6.4 Incidents or Accidents. thX shall promptly notify Talis in writing of any incident
or accident experienced by thX that thX in its reasonable judgment believes may affect the quality of the Product that thX is obligated to deliver hereunder or its ability to meet delivery date obligations hereunder. thX shall promptly investigate
such incident or accident and provide a written report within [...***...] of the results of the investigation of such incidence or accident to Talis and in accordance with the Quality Agreement. 

6.5 Regulatory Support. Except as otherwise expressly set forth herein, Talis shall be responsible for all filings necessary for
approval to market Talis’ own products incorporating the Products. thX agrees to promptly provide to Talis such information relating to the Product or the manufacture thereof as may be necessary or useful in connection therewith. 

7. IP RIGHTS 
 7.1
Ownership. As between the Parties, subject to the terms of this Agreement, thX shall at all times be and remain the sole and exclusive owner of all right, title and interest (including 

  
 17. 

 
all IP Rights) in and to all thX Background IP, thX Background Improvements and thX Manufacturing and Process IP (“thX IP”). If new thX Manufacturing and Process IP will be
required, thX will develop it at its own cost, and in such case, the new thX Manufacturing and Process IP will be thX IP. All rights to Work Product, including all IP Rights therein, all Product IP, and all Talis Background IP (collectively,
“Talis IP”), shall be owned solely by Talis, and thX hereby assigns to Talis all of thX’s right, title and interest in and to Talis IP. thX represents and warrants to Talis that each employee, agent, consultant and
subcontractor of thX is obligated to assign all of his/her/its right, title and interest in and to Work Product and Talis IP to thX. thX shall sign and deliver to Talis all writings and do all such things as may be necessary and reasonable to vest
in Talis all right, title and interest in and to Talis IP. Talis may, in its sole discretion, file and prosecute in its own name and at its own expense, patent applications on any patentable inventions within the Work Product. Notwithstanding the
foregoing, Talis may never reference or introduce any Confidential Information of thX in any patent or other application for intellectual property. At the request and expense of Talis, thX shall assist Talis in the preparation, filing and
prosecution of such patent applications and will execute and deliver any and all instruments necessary to effectuate the ownership of such patent applications and to enable Talis to file and prosecute such patent applications in any country. All
Work Product and IP Rights therein are Confidential Information of Talis. 
 7.2 License to Talis. thX hereby grants to Talis
a worldwide royalty free, fully paid-up, irrevocable, perpetual license under the thX Background Improvements that are embedded in or used in the production of the Products, (a) to use, sell, offer for
sale, import, display, and distribute, the Products or any deliverables provided by thX to Talis hereunder, and (b) to make and have made Products (i) for internal R&D purposes only for the term of this Agreement and (ii) solely
to the extent permitted by the License Agreement, for commercial purposes. 
 7.3 No Implied Licenses. Other than as set out
in Section 7.1, Section 7.2 or in the License Agreement, neither thX nor Talis transfers or licenses to the other by operation of this Agreement any interest in or license to any IP Rights. 

8. PAYMENT 
 8.1
Payment for Products. The purchase price of Products ordered by Talis pursuant to this Agreement shall be as set forth in EXHIBIT A hereto, with delivery terms as stated herein;
prices are net without value added tax (VAT), shipping, duties or other costs. 
 8.2 Payment for Materials, Equipment or
Tools. Other than as expressly set out herein, Talis shall be responsible for all payments to Third Parties for any materials, Equipment or Tools purchased from, or other products or services provided by, Third Parties in
connection with the manufacture and supply of Products hereunder including, without limitation, any duties and sales, use or VAT taxes incurred in the procurement and transfer of ownership to thX, but excluding income taxes incurred by thX. 

8.3 Prices. Prices that are set forth in Exhibit A may not be increased until [...***...]. Before the [...***...],
thX and Talis will initiate price negotiations to set the prices for the subsequent calendar year (subject to the following). Prices may not increase, however, more than by a fixed percentage per year equal to (x) [...***...] 

  
 18. 

 [...***...]. In the situation where thX will increase prices, [...***...]. thX may reduce
the purchase price of any Product at any time during the term of this Agreement. Such revisions shall apply to all Purchase Orders (or any Annual Commitment PO) submitted by Talis after such price reduction. thX and Talis shall agree in good faith
on cost reduction goals and shall work together to achieve such goals via process changes, material changes and other improvements to Products. In addition, [...***...]. 

8.4 Invoices. thX shall invoice Talis for the aggregate purchase price of each single shipment of Product at the time of
shipment of such order. For non-recurring engineering or similar charges for which Talis is responsible hereunder (e.g., validation and Tools development fees, if requested by Talis under a statement of work),
invoicing will occur on a monthly basis on the rates stated in the statement of work.  
 8.5 Method of Payment. All
undisputed payments due under this Section 8 to thX shall be paid to thX in in the currency designated in the pricing schedule set forth in Exhibit A net thirty (30) days after receipt of the applicable invoice, except as set forth in
Section 3.6. Payment by Talis shall not be construed as acceptance of any improper, nonconforming or defective Product, nor shall it be construed as a waiver of any of Talis’ rights or remedies under this Agreement. Any disputed payments
must be brought to thX’s attention within 10 business days after receipt of the applicable invoice and the parties agree to in good faith resolve the dispute within thirty (30) days, otherwise the amount shall be considered undisputed.

 8.6 Taxes. Talis shall make all payments to thX under this Agreement [...***...]. thX shall not invoice Talis for any
value-added tax incurred by thX in performing the obligations under this Agreement unless approved in advance in writing by Talis. 
 9.
REPRESENTATIONS AND WARRANTIES; DISCLAIMER 
 9.1 Mutual
Representations and Warranties. Each Party represents and warrants that (a) such Party is duly organized, validly existing, and in good standing under the laws of the place of its establishment or incorporation, (b) such Party has
taken all action necessary to authorize it to enter into this Agreement and perform its obligations under this Agreement, (c) this Agreement will constitute the legal, valid and binding obligation of such Party, and (d) neither the
execution of this Agreement nor the performance of such Party’s obligations hereunder will conflict with, result in a breach of, or constitute a default under any provision of the organizational documents of such Party, or of any law, rule,
regulation, authorization or approval of any government entity, or of any agreement to which it is a Party or by which it is bound. 

  
 19. 

 9.2 thX Warranties. thX hereby warrants to Talis that (a) the thX IP does
not infringe or misappropriate any [...***...] IP Rights and thX has not received any written communication from any Person alleging to the contrary; (b) that for the Warranty Period all Products supplied under this Agreement shall
(i) conform to the Specifications, (ii) not contain defects in material and workmanship and (iii) at the time of delivery, be free and clear of any lien or encumbrance and (c) its manufacturing processes shall be in accordance
with all applicable regulatory approvals, and all other applicable laws, rules and regulations (including health, safety and environmental laws). In addition, thX hereby grants to Talis, and Talis shall have the right to extend to its customers for
Talis products that use or incorporate Products, the Product Warranty in this Section, for a period beginning on the date of production of a Product for Talis and ending the earlier of (x) [...***...] thereafter or (y) [...***...] as set
by Talis (such period, the “Warranty Period”), provided that such warranty shall not be deemed breached to any Product failure that [...***...]. The warranties made by thX pursuant to this Section are collectively referred to
herein as the “Product Warranty”. This warranty will not apply to Products that: (i) are changed or modified; or (ii) fail solely due to any products not supplied by thX, or system with which the Product is used.
Talis’s sole and exclusive remedy (other than thX’s indemnification obligations) for any rejection of the Products for any reason, a product defect or a breach of warranty will be limited to, at thX’s option, replacement, repair or
refund of the purchase price of the Products that does not conform with the warranties. 
 9.3 Disclaimer. Except as expressly
set forth herein, EACH PARTY EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE WARRANTIES OF DESIGN, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE,
NON-INFRINGEMENT OF THE INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES, OR ARISING FROM A COURSE OF DEALING, USAGE OR TRADE PRACTICES. 

9.4 Limitation of Liability. EXCEPT WITH RESPECT TO INDEMNIFICATION OBLIGATIONS CONTAINED IN SECTION 12 AND FOR BREACHES OF
SECTIONS 7 OR 10, NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY, REGARDLESS OF THE NUMBER OF CLAIMS, (I) ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT OR (II) AGGREGATE
DAMAGES IN EXCESS OF THE AMOUNTS ACTUALLY PAID BY TALIS TO THX FOR PRODUCTS AND SERVICES IN THE 12 MONTH PERIOD PRIOR TO THE DATE OF THE EVENT GIVING RISE TO A CLAIM FOR DAMAGES. 

9.5 Epidemic Failure. For the purposes of this Agreement, “Epidemic Failure” shall be deemed to have occurred
if more than: 
 (i) [...***...] ([...***...]%) during the [...***...] following automated manufacturing; 

  
 20. 

 (ii) [...***...] percent ([...***...]%) during the [...***...] following
automated manufacturing; and 
 (iii) [...***...] ([...***...]%) for the [...***...] following automated manufacturing and
the following years thereafter, of Product shipped to customers should fail in conforming to the Specifications in the same manner during such Product’s applicable Warranty Period, due to a breach of the Product Warranty. In the case of
Epidemic Failure, thX and Talis shall cooperate to implement the following procedure: 
 (a) Talis shall promptly notify thX upon
discovery of the failure. 
 (b) Within [...***...], thX shall give an initial written response indicating its plan for
diagnosing the problem. 
 (c) thX and Talis shall jointly commit and contribute to a failure analysis process to diagnose the
problem and plan a permanent solution and, if necessary, a work-around for temporary use until the solution is implemented. thX and Talis shall mutually agree on a recovery plan, including the implementation of the work-around and the permanent
solution. Where appropriate, thX shall apply its engineering change order procedure for problems originating in the manufacturing process. 

(d) thX shall promptly provide conforming Products to replace all defective Products, as well as all Products which may be susceptible
to the same failure mode. 
 (e) [...***...] actually incurred in rectifying any Epidemic Failure for any solutions,
work-arounds, recovery plans, replacements and engineering changes, as provided in Section 9.5(c), above. 
 9.6 Chronic
Supply Delay. In the case of a Chronic Supply Delay, thX shall (i) conduct a root cause analysis to identify the cause of the supply failure and provide to Talis a written report detailing the cause of the supply failure, and
(ii) deliver a corrective action plan to Talis which plan shall identify the steps thX will take to remedy the supply failure and mitigate the likelihood of reoccurrence, including a schedule for implementation of the plan. 

10. CONFIDENTIALITY 

10.1 Confidentiality. Each Party agrees that, during the Term and for a period of [...***...] thereafter, such Party will
protect and hold the other Party’s Confidential Information in trust and confidence, that it will not use such Confidential Information in any manner or for any purpose not expressly set forth in this Agreement, and will not disclose any such
Confidential Information to any Third Party without first obtaining the other Party’s express written consent on a case-by-case basis. In addition, and except as
permitted by Section 10.3, neither party shall not disclose the existence this Agreement to any Third Party at any time during the Term. In addition to its other confidentiality obligations herein, thX will ensure that Talis’ Confidential
Information (including, but not limited to, Talis IP) is physically segregated from any such information or intellectual property of thX’s other customers. 

  
 21. 

 10.2 Exceptions. Confidential Information of a disclosing Party shall not
include information which the receiving Party can demonstrate by competent evidence: (a) is now, or hereafter becomes, through no breach of this Agreement by the receiving Party, generally known or available; (b) is known by the receiving
Party at the time of receiving such information from the disclosing Party, as evidenced by its written records, provided that thX shall be deemed the receiving Party and Talis the disclosing Party with respect to the Work Product and Talis
IP; (c) is hereafter furnished to the receiving Party by a Third Party, as a matter of right and without restriction on disclosure; or (d) is independently developed by the receiving Party without the use of or reference to Confidential
Information received from the disclosing Party, as evidenced by the receiving Party’s written records. 
 10.3 Authorized
Disclosure. Each Party may disclose Confidential Information belonging to the other Party to the extent such disclosure is reasonably necessary in the following instances: (a) in the case of Talis, to obtain and maintain regulatory
approvals with respect to Talis products that incorporate Products; (b) complying with applicable court orders or applicable laws, rules or regulations; (c) disclosure to a Party’s Affiliates, provided that Confidential Information so
disclosed shall remain subject to this Section 10; and (d) disclosure to Third Parties in connection with due diligence or similar investigations by such Third Parties, and disclosure to potential Third Party investors in confidential
financing documents; provided, however, in each case, that any such Third Party agrees to be bound by reasonable obligations of confidentiality and non-use. In addition, in the event a Party is required
to make a disclosure of the other Party’s Confidential Information pursuant to the preceding clause (b), it will, except where impracticable, give reasonable advance notice to the other Party of such disclosure and, at the other
Party’s request and expense, cooperate with the other Party’s efforts to obtain a protective order preventing or limiting the disclosure and/or requiring that the Confidential Information so disclosed be used only for the purposes for
which the law or regulation requires, or for which the order was issued. 
 11. TERM; TERMINATION 

11.1 Term. Subject to earlier termination according to the provisions of Section 11.2, the initial term of this Agreement
shall commence on the Effective Date and shall continue until the tenth (10th) anniversary of the Effective Date (the “Initial Term”). Thereafter, the Agreement shall continue in force until (a) Talis provides 24-months advance written notice of non-renewal (which notice, for clarity, may be given 24-months in advance of the end of the Initial
Term), in which case the Agreement will terminate at the end of the relevant 24-month notice period or such other date as may be specified on such notice beyond such
24-month period, or (b) either Party otherwise terminates this Agreement in accordance with Section 11.2 (the period beyond the Initial Term during which the Agreement remains in force, the
“Extension Term” and collectively with the Initial Term, the “Term”). 
 11.2 Early Termination.

 (a) Material Breach. Either Party shall have the right to terminate this Agreement upon ninety (90) days written
notice if the other Party materially breaches or defaults on any material obligation under this Agreement (with such notice to provide reasonable detail as to the alleged breach), unless, before the end of the ninety (90) day period, such other
Party has cured the default or breach and so notifies the non-breaching Party in writing, stating the manner 

  
 22. 

 
of the cure. For clarity, but without limiting the generality of the foregoing (i) consistent failures by thX to deliver Product that meets the applicable Specifications in all material
respects that breaches the Product Warranty in four or more shipments in any 4-month period; (ii) constant and consistent material failures by thX under the Quality Agreement; or (iii) two or more
(A) Chronic Supply Delays or (B) Epidemic Failures in any consecutive 12-month period in each case of (i)-(ii) constitute a material breach by thX; and (iv) a material failure by Talis to make
undisputed payment amounts when due would constitute a material breach by Talis; (v) termination of the statement of work related to the semi-automated Production Line by Talis based on thX’s failure to activate such semi-automated
Production Line by the date set forth in the relevant Statement of Work despite its good faith effort to do so, and (vi) a breach of Section 7 by Talis are each a material obligation subject to the first sentence of this
Section 11.2(a). Notwithstanding the foregoing, Talis may not terminate this Agreement for a material breach under item (i) of this Section until the affected Product, that is the subject of the termination, is manufactured in the
automated manufacturing environment. 
 (b) Bankruptcy. A Party shall have the right to terminate this Agreement upon written
notice to the other Party upon or after the filing or institution of bankruptcy, reorganization, liquidation or receivership proceedings by or against the other Party, or upon an assignment of a substantial portion of the other Party’s assets
for the benefit of creditors; provided, however, that in the case of any involuntary bankruptcy proceeding such right to terminate shall only become effective if the Party consents to the involuntary bankruptcy or such proceeding is not
dismissed within ninety (90) days after the filing thereof. 
 (c) Termination at Will. Talis shall have the right to
terminate this Agreement at any time on or after the seventh anniversary of the Effective Date for any reason or for no reason upon delivery of at least two (2) years’ written notice to thX. 

11.3 Effect of Expiration or Termination; Surviving Obligations. 

(a) Upon any termination of this Agreement, all rights and obligations of the Parties hereunder shall terminate and be of no further
force or effect, except as otherwise expressly set forth below in this Section. Upon any termination of this Agreement other than by thX under Section 11.2, Talis may elect to (i) have thX fulfill, in accordance with the applicable terms
and conditions of this Agreement, any or all binding Purchase Orders for Products submitted by Talis prior to the effective date of termination (in which case Talis agrees to pay thX the purchase price for such Products as set forth in this
Agreement), or (ii) cancel such Purchase Orders (or Annual Commitment PO). 
 (b) Expiration or termination of this Agreement
shall not terminate the License Agreement. 
 (c) In the event of any termination of this Agreement, each Party shall return to the
other Party all Confidential Information of the other Party (including all copies thereof) in such Party’s possession; provided, however, that except as set forth below in this Section, each Party may retain one copy of the other
Party’s Confidential Information in such Party’s legal archives for the sole purpose of ensuring compliance with its obligations hereunder and complying with applicable laws and regulations; and provided, further, that thX shall
only retain that Confidential 

  
 23. 

 
Information of Talis that, upon advice of counsel, thX is required to retain to comply with applicable laws, rules and regulations. thX shall give Talis all reasonable opportunities to minimize
the amount of Confidential Information of Talis that thX is required to retain. 
 (d) Upon any termination or expiration of this
Agreement, thX shall: (i) transfer title and deliver to Talis all finished Product completed prior to the effective date of such termination and (ii) return or dispose of property that is subject to Section 2.4 in accordance with
Talis’ reasonable instructions and with Section 2.4 (provided that Talis will reimburse thX for the actual, reasonable costs associated with such disposal). Notwithstanding the foregoing, upon any termination or expiration of this
Agreement (other than by Talis pursuant to Section 11.2(a)), any Tools paid for by Talis that are subject to Section 2.4 will be destroyed as opposed to returned provided that thX will provide notice to Talis indicating such complete
destruction. Upon termination of this Agreement by thX under Section 11.2, Talis shall purchase, in accordance with the applicable terms and conditions of this Agreement, any or all Purchase Orders (including any Annual Commitment PO) for
Products submitted by Talis prior to the effective date of termination (in which case Talis agrees to pay thX the purchase price for such Products as set forth in this Agreement) along with the cost of all raw materials purchased in support thereof.
Also, on termination, thX will provide evidence of having decommissioned and destroyed [...***...]. 
 (e) Neither
expiration nor termination of this Agreement for any reason shall relieve either Party of any obligation accruing prior to such expiration or termination, including without limitation, Talis’s obligation to purchase Minimum Safety Stock
hereunder. The obligations and rights of the Parties under Sections 4.1(d), 4.2(d), 5.2, 7, 8, 9.1 through 9.4, 10, this Section 11.3, 12, 13 and under the applicable provisions of the License Agreement shall survive expiration or termination
of this Agreement. 
 (f) All documentation shall be retained for 10 years after shipment of the relevant Product (or for such longer
period as is required under the Quality Agreement). 
 11.4 Rights Upon Bankruptcy. All rights and licenses granted to Talis
under or pursuant to this Agreement are, and shall otherwise be deemed to be, for purposes of Section 365(n) of Title 11 of the United States Code (collectively, the “Code”), licenses of rights to be “intellectual
property” as defined under the Code. If a case is commenced during the Term by or against thX under the Code then, unless and until this Agreement is rejected as provided in the Code, thX (in any capacity, including debtor-in-possession) and its successors and assigns (including a trustee) shall perform all of the obligations provided in this Agreement to be performed by thX. If a case is
commenced during the Term by or against thX under the Code, this Agreement is rejected as provided in the Code and Talis elects to retain its rights hereunder as provided in the Code, then thX (in any capacity, including debtor-in-possession) and its successors and assigns (including a Title 11 trustee), shall provide to Talis copies of such intellectual property and all embodiments
thereof necessary for Talis to maintain and enjoy its rights under the terms of this Agreement promptly upon Talis’ written request therefor. All rights, powers and remedies of Talis as provided herein are in addition to and not in substitution
for any and all other rights, powers and remedies now or hereafter existing at law or in equity (including, without limitation, the Code) in the event of the commencement of a case by or against thX under the Code. 

  
 24. 

 11.5 Disaster Recovery/Business Continuity. The Parties shall mutually
create and maintain a Business Continuity and Disaster Recovery Plan (the “Plan”) and implement such Plan in the event of any interruption of such performance. On or before the implementation of the semi-automated Production Line ,
the Parties shall create and test the Plan . thX shall immediately notify Talis of any disaster or other event in which the Plan is activated. Without limiting thX’s obligations under this Agreement, whenever a disaster causes thX to allocate
limited resources between or among thX’s customers, Talis shall receive at least the same treatment as comparable thX customers with respect to such limited resources. To further reduce the risk of loss of Product supply, Talis may maintain
stocks of finished Consumables at different locations than at thX. 
 12. INDEMNIFICATION; INSURANCE 

12.1 Indemnification by Talis. Talis hereby agrees to defend, indemnify and hold harmless thX and its officers, directors,
employees, consultants and agents (“thX Indemnitees”) from and against any and all losses, damages, fines, settlements, liabilities, expenses and costs, including reasonable legal expense and attorneys’ fees (collectively,
“Losses”), to which any such thX Indemnitee may become subject as a result of any claim, demand, action or other proceeding by any Third Party to the extent such Losses arise out of a claim relating to personal injury, property
damage or death resulting from product defects in Talis’ own products (where such defect is independent of any Product Defect to any Product used with or incorporated into such Talis product). 

12.2 Indemnification by thX. thX hereby agrees to defend, indemnify and hold harmless Talis and its officers, directors,
employees, consultants, contractors and agents (“Talis Indemnitees”) from and against any and all Losses to which any such Talis Indemnitee may become subject as a result of any claim, demand, action or other proceeding by any
governmental entity or any Third Party to the extent such Losses arise out of a claim relating to personal injury, property damage or death resulting from Product Defects in the Products. 

12.3 General Conditions of Indemnification. Each Party’s agreement to indemnify, defend and hold the other Party harmless
is conditioned on the indemnified Party (a) providing written notice to the indemnifying Party of any claim for which it is seeking indemnification hereunder promptly after the indemnified Party has knowledge of such claim; (b) permitting
the indemnifying Party to assume full responsibility to investigate, prepare for and defend against any such claim or demand; (c) assisting the indemnifying Party, at the indemnifying Party’s reasonable expense, in the investigation of,
preparation for and defense of any such claim or demand; and (d) not compromising or settling such claim or demand without the indemnifying Party’s written consent. 

12.4 Insurance. thX shall at all times during the Term and for a period of [...***...] thereafter, at its own expense,
maintain with financially sound and reputable insurers commercial liability insurance and product liability insurance (each for property damage and bodily injury) with coverage and minimum limits of $[...***...] per occurrence and
$[...***...] in the aggregate, workers compensation insurance for all employees as statutorily defined by state and federal law, and property insurance in an amount sufficient to cover all Products and other personal property while in transit
to Talis and all of thX’s property, including Equipment, for its full replacement value, and shall name Talis as an additional insured with respect to such insurance. thX shall 

  
 25. 

 
provide a certificate of insurance evidencing such coverage to Talis upon request. thX shall provide Talis with [...***...] advance written notice in the event of a cancellation or material
change in such insurance policy. thX waives and thX shall cause its insurers to waive, any right of subrogation or other recovery against Talis, its Affiliates, and their insurers. 

13. MISCELLANEOUS 

13.1 Injunctive Relief. Each Party acknowledges and agrees that, due to the unique and valuable nature of the other Party’s
proprietary information and materials, there may be no adequate remedy at law for any breach by such Party of the provisions of this Agreement, that any such breach may result in irreparable harm to the other Party for which monetary damages may be
inadequate to compensate such Party and that the other Party shall have the right, in addition to any other rights available under applicable law, to obtain from any court of competent jurisdiction injunctive relief to restrain any breach or
threatened breach of, or otherwise to specifically enforce, any covenant or obligation of such Party under such provisions. 
 13.2
Assignment; Delegation. This Agreement may not be assigned by either Party without the prior written consent of the other Party, except that either Party may assign this Agreement to an Affiliate, unless such Affiliate is a competitor of the
other Party, provided that the assigning Party shall remain liable and responsible to the non-assigning Party hereto for the performance and observance of all such duties and obligations by such Affiliate, or
in connection with a Change of Control of such Party. This Agreement shall inure to the benefit of and be binding upon each Party signatory hereto, its successors and permitted assigns. No assignment shall relieve either Party of the performance of
any accrued obligation that such Party may then have under this Agreement. Talis may not delegate or subcontract any of its payment obligations under this Agreement, except with thX prior written consent. thX may not delegate or subcontract any of
its obligations under this Agreement (other than to [...***...]), except upon Talis’ prior written consent. thX shall at all times be responsible for the payment of its permitted subcontractors, and for the compliance of its permitted
subcontractors with the terms and conditions of this Agreement. 
 13.3 Publicity. No Party shall issue a press release
or public announcement or otherwise make any public disclosure concerning the subject matter of this Agreement, without the prior written approval of the other Party. 

13.4 Relationship of Parties. The Parties’ relationship, as established by this Agreement, is solely that of independent
contractors. This Agreement does not create any partnership, joint venture or similar business relationship between the Parties. Except as expressly provided herein, neither Party is a legal representative of the other Party, and neither Party can
assume or create any obligation, representation, warranty or guarantee, express or implied, on behalf of the other Party for any purpose whatsoever. 

13.5 Entire Agreement; Amendment. This Agreement, together with all Exhibits attached hereto, is both a final expression of the
Parties’ agreement and a complete and exclusive statement with respect to all of its terms. This Agreement supersedes all prior and contemporaneous agreements and communications between the Parties, whether oral, written or otherwise,
concerning any and all matters contained herein, including, without limitation, the 

  
 26. 

 
Development Services Agreement. No amendment, modification or addition to this Agreement shall be binding upon the Parties hereto unless reduced to writing and signed by the respective authorized
officers of the Parties. 
 13.6 Severability. If any provision of this Agreement shall be deemed void in whole or in part for
any reason whatsoever, the remaining provisions shall remain in full force and effect. The Parties shall make a good faith effort to replace any such provision with a valid and enforceable one such that the objectives contemplated by the Parties
when entering this Agreement may be realized. 
 13.7 Non-Waiver. The failure of a
Party to insist upon strict performance of any provision of this Agreement or to exercise any right arising out of this Agreement shall neither impair that provision or right nor constitute a waiver of that provision or right, in whole or in part,
in that instance or in any other instance. Any waiver by a Party of a particular provision or right shall be in writing, shall be as to a particular matter and, if applicable, for a particular period of time, and shall be signed by such Party. 

13.8 Governing Law. This Agreement shall be governed by and construed under the laws of the State of Illinois, without reference
to its conflicts of law principles. The United Nations Conventions on Contracts for the International Sale of Goods shall not be applicable to this Agreement. 

13.9 Venue. Any dispute, controversy or claim arising out of or relating to this Agreement, will be made exclusively in
the state or federal courts located in Chicago, Illinois and both Parties submit to the jurisdiction and venue of such courts. 

13.10 Force Majeure. A Party shall be excused from performing its obligations under this Agreement if its performance is delayed
or prevented by any event beyond such Party’s reasonable control, including but not limited to, acts of God, fire, explosion, weather, disease, war, insurrection, civil strife, riots, government action, power failure, earthquake, tsunami or
terrorism (each a “Force Majeure Event”), provided that such performance shall be excused only to the extent of and during such Force Majeure Event. The affected Party shall notify the other Party of such Force Majeure Event as soon
as reasonably practical and shall take reasonable efforts to remove the Force Majeure Event or to avoid its affects so as to resume performance as soon as practicable. A Force Majeure Event shall not give rise to a right for either Party to
terminate this Agreement. 
 13.11 Notices. Any notice required or permitted to be given under this Agreement shall be in
writing, shall specifically refer to this Agreement, and shall be addressed to the appropriate Party at the address specified below or such other address as may be specified by such Party in writing in accordance with this Section, and shall be
deemed to have been given for all purposes: (a) upon personal delivery to the Party to be notified; (b) when sent by confirmed electronic mail if sent during normal business hours of the recipient, if not, then on the next Business Day;
(c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. 

  
 27. 

			
	 If to thX:
	  	 thinXXS Microtechnology AG

Amerikastr. 21

66482 Zweibrücken, Germany

Attention: General Manager

		
	 With a copy to:
	  	 IDEX Corporation

1925 West Field Court

Lake Forest, IL 60045

Attention: Legal Department

		
	 If to Talis:
	  	 Talis Biomedical Corp.

230 Constitution Dr.

Menlo Park, CA 94025

Attention: Legal Dept.

 13.12 Interpretation. The following rules of interpretation apply to this Agreement: (a) he
headings of clauses contained in this Agreement are inserted solely for convenience and ease of reference only and shall not constitute any part of this Agreement, or have any effect on its interpretation or construction; (b) ambiguities and
uncertainties in this Agreement, if any, shall not be interpreted against either Party, irrespective of which Party may be deemed to have caused the ambiguity or uncertainty to exist; (c) definitions contained in this Agreement are applicable
to the singular as well as the plural forms of such term; (d) references to an agreement or instrument mean such agreement or instrument as from time to time amended, modified or supplemented; and (e) in the event of a conflict between the
body of this Agreement and a statement of work, the provisions of this Agreement shall take precedence unless and to the extent that a statement of work expressly provides that its terms are meant to take precedence. References to a Person are also
to its permitted successors and assigns; 
 13.13 Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original and all of which together shall constitute one instrument. This Agreement may be executed by facsimile or PDF signatures, which signatures shall have the same force and effect as original signatures. 

[SIGNATURE PAGE FOLLOWS] 

  
 28. 

 IN WITNESS WHEREOF, the Parties hereto
have duly executed this Supply Agreement as of the Effective Date. 
  

									
	 THINXXS MICROTECHNOLOGY AG
	 		 	 TALIS BIOMEDICAL CORPORATION

					
	By:	 	/s/ Joe Rytell	 		 	By:	 	/s/ Brian Coe
					
	Name:	 	Joe Rytell	 		 	Name:	 	Brian Coe
					
	Title:	 	President, IDEX Health & Science	 		 	Title:	 	Chief Executive Officer

  

  

SIGNATURE PAGE TO SUPPLY AGREEMENT 

 EXHIBIT A 

PRODUCTS 
 [...***...] 

  
 30. 

 [...***...] 

  
 31. 

 [...***...] 

  
 32. 

 [...***...] 

  
 33. 

 EXHIBIT B 

[QUALITY AGREEMENT TO BE ATTACHED] 

  
 B-1 

 EXHIBIT C 

[LICENSE AGREEMENT TO BE ATTACHED] 

  
 C-1EX-10.14

 Exhibit 10.14 

 
 

 
 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL
AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1 I 35 2. AM ENDMENT/M CODIFICATION NO . 3. EFFECTIVE DATE 4 REQUISITE ION/PU RCHASE REO NO. 15. PROJECT NO. (/I applicable) P00
001 58725 1 0 See Block 16C 6. ISSUED BY CODE NHLB I 7. ADMINISTERED BY (If other than Item 6) CODE [NHLBI National Institutes of Health/NHLBI National Institutes of Health/ NHLBI 670 5 Rock ledge Drive Office of Acquisitions RKL1 , 5th Floor 6705
Rockledge Drive Attn : Jonathan Lear, Contracting Officer Rockledge 1 , 5th Floor 3 01 - 827- 7716 Bethesda , MD 2 0892- 7511 Bethesda , MD 20892 - 7511 8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State andZIPCode) 9A. AMENDMENT OF
SOLICITATION NO ~ T ALIS BIOMEDI CAL CORPORATION: 1191536 2 3 0 CONST ITUTION DRIVE 9B . DATED (SEE ITEM 11) MENLO PARK CA 940251 109 X 10A. MODIFICATION OF CONTRACT/ORDER NO 7 5N92 020C00010 10B DATED (SEE ITEM 13) CODE FACILITY CODE 07/3 0/202 0
11. T HIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS : IIUHIIHI till Hers must acknowledge reception this amendment prior to the hour and date specified In the solicitation or as amended . by one of the following methods. (a) By complet1ng
Items 8 and 15. and returning copies of the amendment. (b) By acknowledging receipt of this amendment an each copy of the offer submitted. or (c) By separate letter or telegram wh1ch Includes a reference to the solicitat1on and amendment numbers .
FA ILURE OF YOUR ACKN:JWLEDGEMENT TO BE RECEI VED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PR IOR TO THE HOUR AND DATE SPEC IFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by v1rtue of th1s amendment you delft to change an offer already
submitted. such change may be made by telegram or letter. Provided each telegram or letter makes reference to the sohatahon end this amendment end received poor to the opemnghour end date specified 12.ACCOUIHINOANDAPPROPRIATION DATA(/1 required) Net
increase : $ 15,300,000.00 See Schedule 13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES T HE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14. CHECK ONE A THIS CHANGE ORDER IS ISSUED PURSUANT TO (Specify autflouty) T HE CHANG
ES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO IN ITEM 10A. B THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (sue// as flanges m paylflg office, 8ppn:>pri8tion data, <>1\;) SET FORTH IN ITEM
14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b). C TH IS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO PUTHORITY OF: D. OT HER (Specify type or modification and autflonty) X FAR 52 . 216- 25, Contract Definitization E. IMPORTANT: Contractor 0 IS
not. [} is rewired to sign this document and rectum 1 copies to the inswing office 14. DESCRIPTION OF AMENDMENT/MODIFICATION (Of9antzed by UCF sect10n head mgs, mc/udmg solicda!Jonlconlract StJbfecl matter where fess1ble.) TITLE : Radix Tech - Tal
is Biomed Cal Hi golly Scald able SARS- CoV- 2 RNA Detection in Minutes PURPOSE : The purpose of this modification is to definitive t h e letter contract . Delivery: 07/29/2021 Delivery Location Code : TDP , BTHOFF Two Democracy Plaza , Bethesda Off
C 2 Democracy Plaza 6707 Democracy Blvd Bethesda 1D 208 17 us Continued .. , Ecopt ac provided horo1n, all and cond1t1onc of the document hoot of roach 3ngod , roman unch::mgod :lnd 1n full force and of foot 15A NAMEANO TITLE OF SIGNER (Type or
print) 16A NAME ANO TITLE OF CONTRACTING OFFICER (Type orprmt) Brian Coe Chief Executive Officer ALLISON M. CRISTMAN 156 CONTRACTOR/OFFEROR 15C OATE SIGNED 166 UNITEO STATES OF AMERICA 16C OATE SIGNED u. c. Digitally signed by Allison M. 12/ 15/2020
Dec 9, 2020 All Crista n -s Crist man ·5 5 (SO]Lia/urea of CG/11 NSN /540·01-1~2~070 STANOARO FORM 30 (REV 10·83) Prev1ous edition unusable Presented by GSA FAR (48 CFR) 53.243 

 

 
 CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED 75N92090C00010/P00001 PAGE OF 2 35 NAME OF OFFEROR OR CONTRACTOR TALIS
BIOMEDICAL CORPORATION: 1191536 ITEM NO. (A) SUPPLIES/SERVICES (B) QUANTITY (C) UNIT (D) UNIT PRICE (E) AMOUNT (F) Payment: Approved By, NHLBI Branch B Invoice Paid By: NIH Commercial Accounts Br 2115 East Jefferson St, MSC 8500 Room 4B-432 Bethesda, MD 20892-8500 Period of Performance: 07/30/2020 to 07/29/2021 Add Item 3 as follows: 3 Stage 3: [***] Obligated Amount: $[***] Delivery To: Bldg. 31/1C14 Product/Service Code: Q301 Product/Service
Description: MEDICAL- LABORATORY TESTING Project Data: 151201.2020.300.COVID-19.DIAG.HN81 NIBIB OD OFFICE OF THE DIRECTOR. 25235 ALL OTHER NON-FED SERVCS.11/19/2020
Accounting Info: [***] Funded: $[***] Add Item 4 as follows: [***] 4 Stage 4: [***] Obligated Amount: $[***] Delivery To: Bldg. 31/1C14 Product/Service Code: Q301 Product/Service Description: MEDICAL- LABORATORY TESTING Project Data: 151201.2020.300.COVID-19.DIAG.HN81 NIBIB OD OFFICE OF THE DIRECTOR. 25235 ALL OTHER NON-FED SERVCS.11/19/2020 Accounting Info: [***] Funded: $[***] Add Item 5 as follows:
Continued [***] NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86) Sponsored by GSA FAR (48 CFR) 53.110 

 

 
 CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED 75N92090C00010/P00001 PAGE OF 3 35 NAME OF OFFEROR OR CONTRACTOR TALIS
BIOMEDICAL CORPORATION: 1191536 ITEM NO. (A) SUPPLIES/SERVICES (B) QUANTITY (C) UNIT (D) UNIT PRICE (E) AMOUNT (F) 5 Stage 5: [***] Obligated Amount: $[***] Delivery To: Bldg. 31/1C14 Product/Service Code: Q301 Product/Service Description: MEDICAL-
LABORATORY TESTING Project Data: 151201.2020.300.COVID-19. DIAG.HN81 NIBIB OD OFFICE OF THE DIRECTOR. 25235 ALL OTHER NON-FED SERVCS.11/19/2020 Accounting Info: [***]
Funded: $[***] [***] 

 PART I. - THE SCHEDULE 

SECTION B - SUPPLIES OR SERVICES AND PRICES/COSTS 

ARTICLE B.1 BRIEF DESCRIPTION OF SERVICES 
 Talis
Biomedical Corporation has developed a highly scalable LAMP-based testing instrument (Talis One) for SARS-CoV-2 RNA detection, suited to the protection of vulnerable and
highly exposed populations (e.g. eldercare facilities, dialysis centers, cancer treatment centers, health care workers). The test is appropriate for NPS and NS sampling either by a paraprofessional or layperson, and is completely automated,
employing a single-use self-contained cartridge and tabletop instrument. The scope of work executed under this contract, includes completing the validation, approval, and production processes in order to
deliver a viable product in a scaled up capacity to the U.S. public. 
 ARTICLE B.2 PRICES 

 

	 	a.	 The total Firm Fixed Price (FFP) amount for this contract is $25,400,000.

  

							
	Pricing Schedule	 
	 Milestone
	  	Description	  	Price	 
	1	  	Stage 1: [***]	  	$	[	***] 
	2	  	Stage 2: [***]	  	$	[	***] 
	3	  	Stage 3: [***]	  	$	[	***] 
	4	  	Stage 4: [***]	  	$	[	***] 
	5	  	Stage 5: [***]	  	$	[	***] 

 ARTICLE B.3 ADVANCE UNDERSTANDINGS 
  

	 	a.	 Commercial Item Status: The services provided by the Contractor under this contract constitutes commercial item
services. 

  

	 	b.	 HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to
include rating this order in accordance with 45 CFR Part 101, Subpart A — Health Resources Priorities and Allocations System. 

  

	 	c.	 Liquidated Damages – Milestone-Based Payments 

 

	 	1.	 If the Contractor fails to deliver the supplies or perform the services within the time specified in this
contract, and the Government terminates this contract in whole or in part for cause, the Contractor shall, in place of actual damages, pay to the Government liquidated damages in the amount of 15% of the amount(s) already disbursed to date under the
contract. 

  

	 	2.	 The Contractor will not be charged with liquidated damages when the delay in delivery or performance is beyond
the control and without the fault or negligence of the Contractor as defined in FAR Clause 52.212-4, Contract Terms and Conditions-Commercial Items, incorporated in this contract. 

  

			
	Contract No. 75N92020C00010	  	Page 4

	 	d.	 Successful performance under this contract requires the Contractor obtain and maintain an Emergency Use
Authorization (EUA) from the Food and Drug Administration (FDA); the Contractor shall copy the NIH Program Manager on all FDA correspondence related to the project, including email communications to and from the FDA. The FDA EAU services provided
under this contract constitute a commercial service to detect SARS-CoV-2. 

  

	 	e.	 Fair Pricing: The Rapid Acceleration of Diagnostics (RADx) application review process determined the cost per
test is competitive with the current market price. The Contractor must comply with applicable federal law to ensure that prices to consumers are offered at fair market rate and at a rate consistent with the objective to increase and improve testing
in the United States. 

  

	 	f.	 Security and Privacy of Protected Health Information (PHI) processed under this contract: In the event the
Contractor meets the definition of either a Covered Entity or Business Associate under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Contractor shall comply with the HIPAA regulatory standards set forth in the Code of
Federal Regulations (CFR) 45 C.F.R. Part 160, Part 162, and Part 164. To the extent that the Contractor engages subcontractors or other Business Associates to provide services under this Contract, and such Subcontractors or Business Associates will
receive or create PHI on behalf of the Contractor, the Contractor shall obtain satisfactory assurances from its business associate that the business associate will appropriately safeguard the PHI. The satisfactory assurances must be in writing,
whether in the form of a contract or other agreement between the Contractor and the business associate. In the event of a security or privacy breach applicable to PHI processed under this contract, in addition to following the procedures set forth
in 45 C.F.R. Part 164, the Contractor shall also immediately notify the NIH via the Contracting Officer (CO) and the Contracting Officer’s Representative (COR). 

 

	 	g.	 In accordance with the goals of the RADx program, the testing capabilities produced under this contract are to
be for utilization within the U.S. and its territories. 

  

	 	h.	 Sharing Data and Reports: The Contractor will be required to provide data and reports (e.g., manufacturing,
supply chain, production rates), which NIH will use to evaluate completion or achievement of milestones, progress toward deliverables, and compliance with the requirements of the contract. NIH may use the data to coordinate with other U.S.
Government Agencies to accelerate development and deployment of innovative COVID-19 diagnostic tests, and ensure effective stewardship of federal funds. Sharing data within the federal government enables NIH
to discuss the project’s challenges and progress with federal agencies offering scientific, manufacturing, and logistics expertise. To ensure that innovations are available to the public as quickly as possible, NIH will leverage established
partnerships with federal agencies, such as FDA, CDC, CMS, ASPR/BARDA, and the Department of Defense, and partnerships with State agencies to propel technologies developed by RADx into widespread use. 

 

	 	i.	 Contractor Facilities: The contractor shall certify that they will maintain their Facility and Equipment in
satisfactory operating condition, as required to enable the contractor to manufacture the Final Product to Specification in accordance with the Scaled up Process and all other applicable laws, regulations, rules or orders. Routine repairs,
preventive maintenance, and service contracts for the Facility and Equipment shall be arranged by contractor at no additional cost to the Government. 

  

	 	j.	 The novel coronavirus (COVID-19) pandemic has introduced new
cybersecurity risks both at the NIH and 

  

			
	Contract No. 75N92020C00010	  	Page 5

	 	
across the globe. NIH and NIBIB recognize that that the high profile nature of the RADx response may attract the attention of highly motivated malicious actors and want vendors to understand that
the risks are real and there is a strong interest in protecting the valued work being conducted through these contracts. NIH and NIBIB are asking vendors to consider their current security posture and to make all reasonable efforts to protect their
environment, Information technology, and the products that are being produced. NIST Special Publication 800-171 can be a useful tool or measuring stick to understand your current security posture as it relates
to government computer security standards. Templates can be found at https://csrc.nist.gov/publications/detail/sp/800-171/rev-2/final. 

 

	 	k.	 Contract Termination: In accordance with FAR 52.212-4(l), the
Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop work hereunder and shall immediately cause any and all of its suppliers
and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the
Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost
principles for this purpose. This paragraph does not give the Government any right to audit the Contractor’s records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.
Note: If the contract is terminated for convenience, the contractor shall only stop work that incurs additional expense, liability, or cost to the Government. 

 

	 	l.	 Contract Termination: In accordance with FAR 52.212-4(m), the
Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with
adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any
and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience. 

SECTION C - DESCRIPTION/SPECIFICATIONS/WORK STATEMENT 

ARTICLE C.1 STATEMENT OF OBJECTIVES AND PERFORMANCE WORK STATEMENT 

Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and
facilities, not otherwise provided by the Government as needed to perform the Statement of Objectives, dated July 29, 2020 and the Performance Work Statement (PWS) set forth in SECTION J – List of Attachments, attached hereto and made a
part of this contract. Work to be performed shall be consistent with the application and preliminary work file submitted by the Contractor and subsequent documentation submitted during the application review process and the discussions between the
parties that have taken place between date of application submission through contract award. 
 ARTICLE C.2 REPORTING REQUIREMENTS 

All reports required herein shall be submitted in electronic format only. All electronic reports submitted shall be compliant with Section 508 of the
Rehabilitation Act of 1973. Additional information about testing documents 

  

			
	Contract No. 75N92020C00010	  	Page 6

 
for Section 508 compliance, including guidance and specific checklists, by application, can be found at: http://www.hhs.gov/web/508/index.html under “Making Files
Accessible.” 
 Reporting requirments as defined in the Deliverables Schedule. 

SECTION D - PACKAGING, MARKING, AND SHIPPING 
 There are
no additional instructions or specifications applicable to this contract other than the delivery instructions contained herein. 
 SECTION E - INSPECTION
AND ACCEPTANCE 
  

	 	a.	 The Contracting Officer or the duly authorized Contracting Officer’s Representative (COR) will perform
inspection and acceptance of materials and services to be provided. 

  

	 	b.	 Inspection and acceptance will be performed utilizing the success criteria outlined in the deliverable
schedule. 

 SECTION F - DELIVERIES OR PERFORMANCE 

ARTICLE F.1 PERIOD OF PERFORMANCE 
 The period of
performance of the contract is July 30, 2020 through July 29, 2021. 
 ARTICLE F.2 DELIVERIES 

Satisfactory performance shall be deemed to occur upon performance of the work described in the Statement of Objectives Article in SECTION C of this contract
and upon delivery and acceptance by the Contracting Officer, or the duly authorized representative, in accordance with the stated delivery schedule. 
 The
deliverables or documentation shall be submitted to the Contracting Officer or designated Contracting Officer’s Representative (COR). 
 SECTION G -
CONTRACT ADMINISTRATION DATA 
 ARTICLE G.1 CONTRACTING OFFICER (CO) 

The following Contracting Officer (CO) will represent the Government for the purpose of this contract: 

Name: Allison Cristman 

Telephone: [***] 
 Email: [***]

 The Contracting Officer is the only person with authority to act as agent of the Government under this contract. Only the Contracting Officer has
authority to: 
 1) direct or negotiate any changes in the Statement of Objectives or Performance Work Statement; 

2) modify or extend the period of performance; 

  

			
	Contract No. 75N92020C00010	  	Page 7

 3) change the deliverables or milestones schedule; 

4) authorize reimbursement to the Contractor for any costs incurred during the performance of this contract; 

5) otherwise change any terms and conditions of this contract. 

All correspondence (including invoices) that proposes or otherwise involves waivers, deviations, or modifications to requirement shall be provided to the CO
issuing the task order and the COR supporting the CO. 
 ARTICLE G.2 CONTRACTING OFFICER’S REPRESENTATIVE (COR) 

The following Contracting Officer’s Representative (COR) is anticipated to represent the Government for the purpose of this contract: 

Olga Hartman, Ph.D. 
 Phone: [***]

 Email: [***] 
 The COR is responsible for:

 (1) monitoring the Contractor’s technical progress, including the surveillance and assessment of performance and recommending to the
Contracting Officer changes in requirements; 
 (2) interpreting the statement of objectives or PWS and any other technical performance
requirements; 
 (3) performing technical evaluation as required; 

(4) performing technical inspections and acceptances required by this contract; and 

(5) assisting in the resolution of technical problems encountered during performance. 

The Government may unilaterally change the COR designation. 

ARTICLE G.3 PRIMARY PROGRAM MANAGER 
 The Primary Program
Manager specified in this contract is considered to be essential to work performance. At least 30 days prior to any changes to the individual listed below to other programs or contracts (or as soon as reasonably possible, if an individual must be
replaced, for example, as a result of leaving the employ of the Contractor), the Contractor shall notify the Contracting Officer and shall submit comprehensive justification for the change request (including proposed substitutions for primary
program manager) to permit evaluation by the Government of the impact on performance under this contract. The Contractor shall not replace any primary program manager without the written consent of the Contracting Officer. The Government may modify
the contract to add or delete primary program manager at the request of the contractor or Government. In no case shall the individual’s effort exceed 100% across all contracts. 

For purposes of this article, [***] will be the Primary Program Manager. 

ARTICLE G.4 INVOICE SUBMISSION 
 In addition to the
requirements specified in FAR 32.905 for a proper invoice, the Contractor shall include the following information on the face page of all contract payment requests: 

  

			
	Contract No. 75N92020C00010	  	Page 8

	 	a.	 The Contract Title is: RADx Tech – Talis Biomedical Highly Scalable SARS-CoV-2 RNA Detection in Minutes 

  

	 	b.	 The Contract Line Items are defined within Section 20, Schedule of Supplies/Services of the Standard Form
1449. 

  

	 	c.	 Invoice Instructions are attached and made part of this contract. The Contractor shall follow the attached
instructions and submission procedures specified below to meet the requirements of a “proper invoice” pursuant to FAR Subpart 32.9, Prompt Payment. 

  

	 	1.	 Payment requests shall be submitted to the offices identified below. Do not submit supporting documentation
(e.g., receipts, time sheets, vendor invoices, etc.) with your payment request unless specified elsewhere in the contract or requested by the Contracting Officer. 

 

	 	a.	 One copy of the invoice shall be submitted to the approving official at the following email addresses:

 NHLBI Branch B Central Email Box: NHLBIContractsBranchB@mail.nih.gov 

NIH Centralized Invoice Email Box: invoicing@nih.gov 

 

	 	2.	 E-Mail: The Contractor shall submit an electronic copy of the payment
request to the approving official. The payment request shall be transmitted as an attachment via e-mail to the address listed above in one of the following formats: MSWord, MS Excel, or Adobe Portable Document
Format (PDF). Only one payment request shall be submitted per e-mail and the subject line of the e-mail shall include the Contractor’s name, contract number, and
unique invoice number. 

  

	 	3.	 In addition to the requirements specified in FAR 32.905 for a proper invoice, the Contractor shall include the
following information on the face page of all payment requests (invoices): 

  

	 	a.	 Name of the Office of Acquisitions. The Office of Acquisitions for this contract is NHLBI.

  

	 	b.	 Central Point of Distribution. For the purpose of this contract, the Central Point of Distribution is NHLBI
Branch B Invoices. 

  

	 	c.	 Federal Taxpayer Identification Number (TIN). If the Contractor does not have a valid TIN, it shall identify
the Vendor Identification Number (VIN) on the payment request. The VIN is the number that appears after the Contractor’s name on the face page of the contract. [Note: A VIN is assigned to new contracts awarded on or after
June 4, 2007, and any existing contract modified to include the VIN number.] If the Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer. 

 

	 	d.	 DUNS or DUNS+4 Number. The DUNS number must identify the Contractor’s name and address exactly as stated
in the contract and as registered in the Central Contractor Registration (CCR) database. If the Contractor does not have a valid DUNS number, it shall identify the Vendor Identification Number (VIN) on the payment request. The VIN is the number that
appears after the Contractor’s name on the face page of the contract. [Note: A VIN is assigned to new contracts awarded on or after June 4, 2007, and any existing contract modified to include the VIN number.] If the
Contractor has neither a TIN, DUNS, or VIN, contact the Contracting Officer. 

  

	 	e.	 Invoice Matching Option. This contract requires a two-way match.

  

	 	f.	 Unique Invoice Number. Each payment request must be identified by a unique invoice number, which can only be
used one time regardless of the number of contracts or orders held by an organization. 

  

			
	Contract No. 75N92020C00010	  	Page 9

	 	g.	 PRISM/NBS Line Item Number and associated PRISM/NBS Line Item Period of Performance (see Section B –
PRICES/OPTION). 

  

	 	d.	 Inquiries regarding payment of invoices shall be directed to the designated billing office, [***].

 ARTICLE G.5 POST AWARD EVALUATION OF CONTRACTOR PERFORMANCE 

A final evaluation of Contractor performance will be prepared on this contract in accordance with FAR Subpart 42.15. The final performance evaluation will be
prepared at the time of completion of work. The final evaluation will be provided to the Contractor as soon as practicable after completion of the evaluation. The Contractor will be permitted thirty days to review the document and to submit
additional information or a rebutting statement. If agreement cannot be reached between the parties, the matter will be referred to an individual one level above the Contracting Officer, whose decision will be final. Copies of the evaluation,
Contractor responses, and review comments, if any, will be retained as part of the contract file, and may be used to support future award decisions. 

Electronic Access to Contractor Performance Evaluations: Contractors may access evaluations through a secure Web site for review and comment at
http://www.cpars.gov. 
 SECTION H - ADDITONAL CONTRACT CLAUSES 

ARTICLE H.1 CONFIDENTIALITY OF INFORMATION 
  

	 	a.	 Confidential information, as used in this article, means information or data of a personal nature about an
individual, or proprietary information or data submitted by or pertaining to an institution or organization. 

  

	 	b.	 The Contracting Officer and the Contractor may, by mutual consent, identify elsewhere in this contract specific
information and/or categories of information which the Government will furnish to the Contractor or that the Contractor is expected to generate which is confidential. Similarly, the Contracting Officer and the Contractor may, by mutual consent,
identify such confidential information from time to time during the performance of the contract. Failure to agree will be settled pursuant to the “Disputes” clause. 

 

	 	c.	 If it is established elsewhere in this contract that information to be utilized under this contract, or a
portion thereof, is subject to the Privacy Act, the Contractor will follow the rules and procedures of disclosure set forth in the Privacy Act of 1974, 5 U.S.C. 552a, and implementing regulations and policies, with respect to systems of records
determined to be subject to the Privacy Act. 

  

	 	d.	 Confidential information, as defined in paragraph (a) of this article, shall not be disclosed without the
prior written consent of the individual, institution, or organization. 

  

	 	e.	 Whenever the Contractor is uncertain with regard to the proper handling of material under the contract, or if
the material in question is subject to the Privacy Act or is confidential information subject to the provisions of this article, the Contractor should obtain a written determination from the Contracting Officer prior to any release, disclosure,
dissemination, or publication. 

  

			
	Contract No. 75N92020C00010	  	Page 10

	 	f.	 Contracting Officer determinations will reflect the result of internal coordination with appropriate program
and legal officials. 

  

	 	g.	 The provisions of paragraph (d) of this article shall not apply to conflicting or overlapping provisions
in other Federal, State or local laws. 

 ARTICLE H.2 PUBLICATION AND PUBLICITY 

In addition to the requirements set forth in HHSAR Clause 352.227-70, Publications and Publicity
incorporated by reference in SECTION I of this contract, the Contractor shall acknowledge the support of the National Institutes of Health whenever publicizing the work under this contract in any media by including an acknowledgment
substantially as follows: 
 “This project has been funded in whole or in part with Federal funds from the National Institute of
Biomedical Imaging and Bioengineering, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92020C00010.” 

ARTICLE H.3 REPORTING MATTERS INVOLVING FRAUD, WASTE AND ABUSE 

Anyone who becomes aware of the existence or apparent existence of fraud, waste and abuse in NIH funded programs is encouraged to report such
matters to the HHS Inspector General’s Office in writing or on the Inspector General’s Hotline. The toll free number is
1-800-HHS-TIPS
(1-800-447-8477). All telephone calls will be handled confidentially. The website to file a complaint online is:
http://oig.hhs.gov/fraud/hotline/ and the mailing address is: 
 US Department of Health and Human Services Office of Inspector
General 
 ATTN: OIG HOTLINE OPERATIONS 

P.O. Box 23489 Washington, D.C. 20026 

ARTICLE H.4 ELECTRONIC AND INFORMATION TECHNOLOGY ACCESSIBILITY, HHSAR 352.239-74 (December 2015) 

 

	 	a.	 Pursuant to Section 508 of the Rehabilitation Act of 1973(29 U.S.C. 794d), as amended by the Workforce
Investment Act of 1998, all electronic and information technology (EIT) supplies and services developed, acquired, or maintained under this contract or order must comply with the “Architectural and Transportation Barriers Compliance Board
Electronic and Information Technology (EIT) Accessibility Standards’’ set forth by the Architectural and Transportation Barriers Compliance Board (also referred to as the “Access Board’’) in 36 CFR part 1194. Information
about Section 508 is available at http://www.hhs.gov/web/508 . The complete text of Section 508 Final Provisions can be accessed at
http://www.access-board.gov/guidelines-and-standards/communications-and-it/about-the-section-508-standards
. 

  

	 	b.	 The Section 508 accessibility standards applicable to this contract or order are identified in the
Statement of Work or Specification or Performance Work Statement. The contractor must provide any necessary updates to the submitted HHS Product Assessment Template(s) at the end of each contract or order exceeding the simplified acquisition
threshold (see FAR 2.101) when the contract 

  

			
	Contract No. 75N92020C00010	  	Page 11

	 	or order duration is one year or less. If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation
of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense. 

  

	 	c.	 The Section 508 accessibility standards applicable to this contract are: 300 – Functional Performance
Requirements 500 – Software Standards General 600 – Support Services & Documentation Standards WCAG Level A Requirements WCAG Level AA Requirements 

 

	 	d.	 In the event of a modification(s) to this contract or order,which adds new EIT supplies or services or revises
the type of, or specifications for, supplies or services, the Contracting Officer may require that the contractor submit a completed HHS Section 508 Product Assessment Template and any other additional information necessary to assist the
Government in determining that the EIT supplies or services conform to Section 508 accessibility standards. Instructions for documenting accessibility via the HHS Section 508 Product Assessment Template may be found under Section 508
policy on the HHS Web site: ( http://www.hhs.gov/web/508 ). If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation of the
supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense. 

  

	 	e.	 If this is an Indefinite Delivery contract, a Blanket Purchase Agreement or a Basic Ordering Agreement, the
task/delivery order requests that include EIT supplies or services will define the specifications and accessibility standards for the order. In those cases, the Contractor may be required to provide a completed HHS Section 508 Product
Assessment Template and any other additional information necessary to assist the Government in determining that the EIT supplies or services conform to Section 508 accessibility standards. Instructions for documenting accessibility via the HHS
Section 508 Product Assessment Template may be found at http://www.hhs.gov/web/508. If it is determined by the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the
provided documentation, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense. 

(End of clause) 
 PART II, SECTION I -
CONTRACT CLAUSES INCORPORATED BY REFERENCE 
 ARTICLE I.1 CONTRACT CLAUSES INCORPORATED BY REFERENCE 

This contract incorporates the following clauses by reference, (unless otherwise noted), with the same force and effect as if they were given in full text.
Upon request, the Contracting Officer will make their full text available. 
 FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES 

 

	 	a.	 FAR Clause 52.203-13, Contractor Code of Business Ethics and Conduct
(October 2015) 

  

	 	b.	 FAR Clause 52.204-13, System for Award Management Maintenance

  

	 	c.	 FAR Clause 52.204-18, Commercial and Government Entity Code Maintenance
(July 2016) 

  

			
	Contract No. 75N92020C00010	  	Page 12

	 	d.	 FAR Clause 52.204-23, Prohibition on Contracting for Hardware,
Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities 

  

	 	e.	 FAR Clause 52.209-10, Prohibition on Contracting With Inverted Domestic
Corporations (November 2015) 

  

	 	f.	 FAR Clause 52.212-3, Offeror Representations and Certifications –
Commerical Items (Jun 2020) 

  

	 	g.	 FAR Clause 52.212-4, Contract Terms and Conditions – Commercial
Items (Oct 2018) 

  

	 	h.	 FAR Clause 52.222-4, Contract Work Hours and Safety Standards -
Overtime Compensation -General (May 2014) 

  

	 	i.	 FAR Clause 52.222-29, Notification of Visa Denial (April 2015)

  

	 	j.	 FAR Clause 52.224-1, Privacy Act Notification (April 1984)

  

	 	k.	 FAR Clause 52.224-2, Privacy Act (April 1984) 

 

	 	l.	 FAR Clause 52.227-1, Authorization and Consent (June 2020)

  

	 	m.	 FAR Clause 52.227-3, Patent Indemnity (April 1984)

  

	 	n.	 FAR Clause 52.227-11, Patent Rights – Ownership by the Contractor
(May 2014) 

  

	 	o.	 FAR Clause 52.227-14, Rights in Data - General (May 2014)

  

	 	p.	 FAR Clause 52.227-14, Rights in Data - General (May 2014) Alternate II
(Dec 2007) 

  

	 	q.	 FAR Clause 52.232-40, Providing Accelerated Payments to Small Business
Subcontractors 

 DEPARTMENT OF HEALTH AND HUMAN SERVICES ACQUISITION REGULATION (HHSAR) CLAUSES: 

HHSAR Clause 352.227-70, Publications and Publicity 

ARTICLE I.2 ADDITIONAL FAR CONTRACT CLAUSES INCLUDED IN FULL TEXT 
  

	 	a.	 FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES 

This contract incorporates the following clauses in full text: 
  

	 	1.	 FAR Clause 52.204-21, Basic Safeguarding of Covered Contractor
Information Systems (Jun 2016) 

  

	 	(a)	 Definitions. As used in this clause – 

Covered contractor information system means an information system that is owned or operated by a contractor that processes, stores, or
transmits Federal contract information. 
 Federal contract information means information, not intended for public release, that is provided
by or generated for the Government under a contract to develop or deliver a product or service to the Government, but not including information provided by the Government to the public (such as on public websites) or simple transactional
information, such as necessary to process payments. 
 Information means any communication or representation of knowledge such as facts,
data, or opinions, in any medium or form, including textual, numerical, graphic, cartographic, narrative, or audiovisual (Committee on National Security Systems Instruction (CNSSI) 4009). 

Information system means a discrete set of information resources organized for the collection, processing, maintenance, use, sharing,
dissemination, or disposition of information (44 U.S.C. 3502). 

  

			
	Contract No. 75N92020C00010	  	Page 13

 Safeguarding means measures or controls that are prescribed to protect information systems.

  

	 	(b)	 Safeguarding requirements and procedures. 

(1) The Contractor shall apply the following basic safeguarding requirements and procedures to protect covered contractor information systems.
Requirements and procedures for basic safeguarding of covered contractor information systems shall include, at a minimum, the following security controls: 
  

	 	(i)	 Limit information system access to authorized users, processes acting on behalf of authorized users, or devices
(including other information systems). 

  

	 	(ii)	 Limit information system access to the types of transactions and functions that authorized users are permitted
to execute. 

  

	 	(iii)	 Verify and control/limit connections to and use of external information systems. 

 

	 	(iv)	 Control information posted or processed on publicly accessible information systems. 

 

	 	(v)	 Identify information system users, processes acting on behalf of users, or devices. 

 

	 	(vi)	 Authenticate (or verify) the identities of those users, processes, or devices, as a prerequisite to allowing
access to organizational information systems. 

  

	 	(vii)	 Sanitize or destroy information system media containing Federal Contract Information before disposal or release
for reuse. 

  

	 	(viii)	 Limit physical access to organizational information systems, equipment, and the respective operating
environments to authorized individuals. 

  

	 	(ix)	 Escort visitors and monitor visitor activity; maintain audit logs of physical access; and control and manage
physical access devices. 

  

	 	(x)	 Monitor, control, and protect organizational communications (i.e., information transmitted or received by
organizational information systems) at the external boundaries and key internal boundaries of the information systems. 

  

	 	(xi)	 Implement subnetworks for publicly accessible system components that are physically or logically separated from
internal networks. 

  

	 	(xii)	 Identify, report, and correct information and information system flaws in a timely manner.

  

	 	(xiii)	 Provide protection from malicious code at appropriate locations within organizational information systems.

  

			
	Contract No. 75N92020C00010	  	Page 14

	 	(xiv)	 Update malicious code protection mechanisms when new releases are available. 

 

	 	(xv)	 Perform periodic scans of the information system and real-time scans of files from external sources as files
are downloaded, opened, or executed. 

 (2) Other requirements. This clause does not relieve the Contractor of any other
specific safeguarding requirements specified by Federal agencies and departments relating to covered contractor information systems generally or other Federal safeguarding requirements for controlled unclassified information (CUI) as established by
Executive Order 13556. 
 (c) Subcontracts. The Contractor shall include the substance of this clause, including this paragraph (c), in
subcontracts under this contract (including subcontracts for the acquisition of commercial items, other than commercially available off-the-shelf items), in which the
subcontractor may have Federal contract information residing in or transiting through its information system. 
 (End of clause) 

 

	 	2.	 FAR 52.212-5 Contract Terms and Conditions Required to Implement
Statutes or Executive Orders- Commercial Items (Aug 2020) 

  

	 	(a)	 The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are
incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial items: 

  

	 	(1)	 52.203-19, Prohibition on Requiring Certain Internal Confidentiality
Agreements or Statements (JAN 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent
appropriations acts (and as extended in continuing resolutions)). 

  

	 	(2)	 52.204-23, Prohibition on Contracting for Hardware, Software, and
Services Developed or Provided by Kaspersky Lab and Other Covered Entities (Jul 2018) (Section 1634 of Pub. L. 115-91). 

 

	 	(3)	 52.204-25, Prohibition on Contracting for Certain Telecommunications
and Video Surveillance Services or Equipment. (Aug 2020) (Section 889(a)(1)(A) of Pub. L. 115-232). 

  

	 	(4)	 52.209-10, Prohibition on Contracting with Inverted Domestic
Corporations (Nov 2015). 

  

	 	(5)	 52.233-3, Protest After Award (Aug 1996) (31 U.S.C. 3553).

  

	 	(6)	 52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004)
(Public Laws 108-77 and 108-78 ( 19 U.S.C. 3805 note)). 

  

	 	(b)	 The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has
indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items: 

  

			
	Contract No. 75N92020C00010	  	Page 15

	 	_X_	 (1) 52.203-6, Restrictions on Subcontractor Sales to the
Government (JUNE 2020), with Alternate I (OCT 1995) ( 41U.S.C.4704 and 10 U.S.C. 2402). 

  

	 	_X_	 (2) 52.203-13, Contractor Code of Business Ethics and Conduct
(JUN 2020) (41 U.S.C. 3509)). 

  

	 	__	 (3) 52.203-15, Whistleblower Protections under the American
Recovery and Reinvestment Act of 2009 (JUN 2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.) 

 

	 	_X_	 (4) 52.204-10, Reporting Executive Compensation and First-Tier
Subcontract Awards (JUN 2020) (Pub. L. 109-282) ( 31 U.S.C. 6101 note). 

  

	 	__	 (5) [Reserved]. 

  

	 	__	 (6) 52.204-14, Service Contract Reporting Requirements
(OCT 2016) (Pub. L. 111-117, section 743 of Div. C). 

  

	 	__	 (7) 52.204-15, Service Contract Reporting Requirements for
Indefinite-Delivery Contracts (OCT 2016) (Pub. L. 111-117, section 743 of Div. C). 

  

	 	_X_	 (8) 52.209-6, Protecting the Government’s Interest When
Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (JUN 2020) (31 U.S.C. 6101 note). 

  

	 	__	 (9) 52.209-9, Updates of Publicly Available Information
Regarding Responsibility Matters (OCT 2018) (41 U.S.C. 2313). 

  

	 	__	 (10) [Reserved]. 

  

	 	__	 (11) (i) 52.219-3, Notice of HUBZone Set-Aside or Sole-Source Award (MAR 2020) (15 U.S.C. 657a). 

  

	 	__	 (ii) Alternate I (MAR 2020) of 52.219-3.

  

	 	__	 (12) (i) 52.219-4, Notice of Price Evaluation Preference for HUBZone
Small Business Concerns (Mar 2020) (if the offeror elects to waive the preference, it shall so indicate in its offer) (15 U.S.C. 657a). 

  

	 	__	 (ii) Alternate I (Mar 2020) of 52.219-4. 

 

	 	__	 (13) [Reserved] 

  

	 	__	 (14) (i) 52.219-6, Notice of Total Small Business Set-Aside (Mar 2020) of 52.219- 6 (15 U.S.C. 644). 

  

	 	__	 (ii) Alternate I (MAR 2020) of 52.219-6 .

  

	 	__	 (15) (i) 52.219-7, Notice of Partial Small Business Set-Aside (Mar 2020) (15 U.S.C. 644). 

  

	 	__	 (ii) Alternate I (MAR 2020) of 52.219-7.

  

	 	_X_	 (16) 52.219-8, Utilization of Small Business Concerns (Oct 2018) (15
U.S.C. 637(d)(2) and (3)). 

  

	 	__	 (17) (i) 52.219-9, Small Business Subcontracting Plan (Jun 2020) (15
U.S.C. 637(d)(4)). 

  

	 	__	 (ii) Alternate I (Nov 2016) of 52.219-9. 

 

	 	__	 (iii) Alternate II (Nov 2016) of 52.219-9. 

 

	 	__	 (iv)Alternate III (Jun 2020) of 52.219-9. 

 

	 	__	 (v)AlteRNATE IV (JUN 2020) OF 52.219-9

  

	 	__	 (18) (i) 52.219-13, Notice of
Set-Aside of Orders (Mar 2020) (15 U.S.C. 644(r)). 

 __ (ii) Alternate I (Mar
2020) of 52.219-13. 
  

	 	__	 (19) 52.219-14, Limitations on Subcontracting (Mar 2020) (15 U.S.C.
637(a)(14)). 

  

	 	__	 (20) 52.219-16, Liquidated Damages-Subcontracting Plan (Jan 1999) (15
U.S.C. 637(d)(4)(F)(i)). 

  

	 	__	 (21) 52.219-27, Notice of Service-Disabled Veteran-Owned Small Business
Set-Aside (Mar 2020) (15 U.S.C. 657f). 

  

	 	_X_	 (22) (i) 52.219-28, Post Award Small Business Program Rerepresentation
(May 2020) (15 U.S.C. 632(a)(2)). 

  

			
	Contract No. 75N92020C00010	  	Page 16

 __ (ii) Alternate I (MAR 2020) of
52.219-28. 
  

	 	__	 (23) 52.219-29, Notice of
Set-Aside for, or Sole Source Award to, Economically Disadvantaged Women-Owned Small Business Concerns (Mar 2020) (15 U.S.C. 637(m)). 

 

	 	__	 (24) 52.219-30, Notice of
Set-Aside for, or Sole Source Award to, Women-Owned Small Business Concerns Eligible Under the Women-Owned Small Business Program (Mar2020) (15 U.S.C. 637(m)). 

 

	 	__	 (25) 52.219-32, Orders Issued Directly Under Small Business Reserves
(Mar 2020)(15 U.S.C. 644(r)). 

  

	 	__	 (26) 52.219-33, Nonmanufacturer Rule (Mar 2020) (15U.S.C. 637(a)(17)).

  

	 	_X_	 (27) 52.222-3, Convict Labor (Jun 2003) (E.O.11755).

  

	 	_X_	 (28) 52.222-19, Child Labor- Cooperation with Authorities and Remedies
(Jan2020) (E.O.13126) 

  

	 	_X_	 (29) 52.222-21, Prohibition of Segregated Facilities (Apr 2015).

  

	 	_X_	 (30) (i) 52.222-26, Equal Opportunity (SEP 2016) (E.O.11246).

  

	 	__	 (ii) Alternate I (FEB 1999) of 52.222-26.

  

	 	_X_	 (31) (i) 52.222-35, Equal Opportunity for Veterans (JUN 2020)
(38 U.S.C. 4212). 

  

	 	__	 (ii) Alternate I (JUL 2014) of 52.222-35.

  

	 	_X_	 (32) (i) 52.222-36, Equal Opportunity for Workers with
Disabilities (JUN 2020) (29 U.S.C. 793). 

  

	 	__	 (ii) Alternate I (JUL 2014) of 52.222-36.

  

	 	_X_	 (33) 52.222-37, Employment Reports on Veterans (Jun 2020) (38
U.S.C. 4212). 

  

	 	_X_	 (34) 52.222-40, Notification of Employee Rights Under the National
Labor Relations Act (Dec 2010) (E.O. 13496). 

  

	 	_X_	 (35) (i) 52.222-50, Combating Trafficking in Persons (JAN 2019) (22
U.S.C. chapter 78 and E.O. 13627). 

  

	 	__	 (ii) Alternate I (MAR 2015) of 52.222-50 (22 U.S.C. chapter
78 and E.O. 13627). 

  

	 	__	 (36) 52.222-54, Employment Eligibility Verification (OCT 2015).
(Executive Order 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial items as prescribed in
22.1803.) 

  

	 	__	 (37) (i) 52.223-9, Estimate of Percentage of Recovered Material
Content for EPA–Designated Items (MAY 2008) ( 42 U.S.C. 6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available
off-the-shelf items.) 

  

	 	__	 (ii) Alternate I (MAY 2008) of 52.223-9 (42 U.S.C.
6962(i)(2)(C)). (Not applicable to the acquisition of commercially available off-the-shelf items.) 

 

	 	__	 (38) 52.223-11,
Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (Jun 2016) (E.O. 13693). 

  

	 	__	 (39) 52.223-12, Maintenance, Service, Repair, or Disposal of
Refrigeration Equipment and Air Conditioners (Jun 2016) (E.O. 13693). 

  

	 	__	 (40) (i) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (JUN 2014) (E.O.s 13423 and 13514). 

  

	 	__	 (ii) Alternate I (OCT 2015) of 52.223-13.

  

	 	__	 (41) (i) 52.223-14, Acquisition of EPEAT®-Registered Televisions (JUN 2014) (E.O.s 13423 and 13514). 

  

	 	__	 (ii) Alternate I (Jun2014) of 52.223-14. 

 

	 	__	 (42) 52.223-15, Energy Efficiency in Energy-Consuming Products
(May 2020) (42 U.S.C. 8259b). 

  

	 	__	 (43) (i) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products (OCT 2015) (E.O.s 13423 and 13514). 

  

			
	Contract No. 75N92020C00010	  	Page 17

	 	__	 (ii) Alternate I (JUN 2014) of 52.223-16. 

 

	 	_X_	 (44) 52.223-18, Encouraging Contractor Policies to Ban Text
Messaging While Driving (Jun 2020) (E.O. 13513). 

  

	 	__	 (45) 52.223-20, Aerosols (Jun 2016) (E.O. 13693).

  

	 	__	 (46) 52.223-21, Foams (Jun2016) (E.O. 13693). 

 

	 	__	 (47) (i) 52.224-3 Privacy Training (JAN 2017) (5 U.S.C.
552 a). 

  

	 	__	 (ii) Alternate I (JAN 2017) of 52.224-3.

  

	 	__	 (48) 52.225-1, Buy American-Supplies (May 2014) (41 U.S.C.
chapter 83). 

  

	 	__	 (49) (i) 52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act
(May 2014) (41 U.S.C.chapter83, 19 U.S.C. 3301 note, 19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109- 283, 110-138, 112-41, 112-42, and 112-43.

  

	 	__	 (ii) Alternate I (May 2014) of 52.225-3. 

 

	 	__	 (iii) Alternate II (May 2014) of 52.225-3. 

 

	 	__	 (iv) Alternate III (MAY 2014) of 52.225-3.

  

	 	__	 (50) 52.225-5, Trade Agreements (Oct 2019) (19 U.S.C. 2501, et
seq., 19 U.S.C. 3301 note). 

  

	 	_X_	 (51) 52.225-13, Restrictions on Certain Foreign Purchases (Jun 2008)
(E.O.’s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury). 

  

	 	__	 (52) 52.225-26, Contractors Performing Private Security Functions
Outside the United States (Oct 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. 2302Note). 

  

	 	__	 (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov 2007) (42 U.S.C. 5150). 

  

	 	__	 (54) 52.226-5, Restrictions on Subcontracting Outside Disaster or
Emergency Area (Nov 2007) (42 U.S.C. 5150). 

  

	 	__	 (55) 52.229-12, Tax on Certain Foreign Procurements (JUN
2020). 

  

	 	__	 (56) 52.232-29, Terms for Financing of Purchases of Commercial
Items (Feb 2002) (41 U.S.C. 4505, 10 U.S.C. 2307(f)). 

  

	 	__	 (57) 52.232-30, Installment Payments for Commercial Items (Jan2017) (41
U.S.C. 4505, 10 U.S.C. 2307(f)). 

  

	 	_X_	 (58) 52.232-33, Payment by Electronic Funds Transfer-System for Award
Management (Oct 2018) (31 U.S.C. 3332). 

  

	 	__	 (59) 52.232-34, Payment by Electronic Funds Transfer-Other than System
for Award Management (Jul 2013) (31 U.S.C. 3332). 

  

	 	__	 (60) 52.232-36, Payment by Third Party (May 2014) (31 U.S.C. 3332).

  

	 	__	 (61) 52.239-1, Privacy or Security Safeguards (Aug 1996) (5 U.S.C.
552a). 

  

	 	__	 (62) 52.242-5, Payments to Small Business Subcontractors (Jan 2017) (15
U.S.C. 637(d)(13)). 

  

	 	__	 (63) (i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial
Vessels (FEB 2006) (46 U.S.C. Appx. 1241(b) and 10 U.S.C. 2631). 

  

	 	__	 (ii) Alternate I (Apr 2003) of 52.247-64. 

 

	 	__	 (iii) Alternate II (FEB 2006) of 52.247-64.

  

	 	(c)	 The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that
the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial items: 

 

	 	__	 (1) 52.222-41, Service Contract Labor Standards (Aug 2018) (41
U.S.C. chapter67). 

  

	 	__	 (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (May

  

			
	Contract No. 75N92020C00010	  	Page 18

	 	
2014) (29 U.S.C. 206 and 41 U.S.C. chapter 67). 

  

	 	__	 (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor
Standards-Price Adjustment (Multiple Year and Option Contracts) (Aug 2018) (29 U.S.C. 206 and 41 U.S.C. chapter 67). 

  

	 	__	 (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor
Standards-Price Adjustment (May 2014) ( 29U.S.C.206 and 41 U.S.C. chapter 67). 

  

	 	__	 (5) 52.222-51, Exemption from Application of the Service Contract Labor
Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May 2014) (41 U.S.C. chapter 67). 

  

	 	__	 (6) 52.222-53, Exemption from Application of the Service Contract Labor
Standards to Contracts for Certain Services-Requirements (May 2014) (41 U.S.C. chapter 67). 

  

	 	__	 (7) 52.222-55, Minimum Wages Under Executive Order 13658 (Dec 2015).

  

	 	__	 (8) 52.222-62, Paid Sick Leave Under Executive Order 13706 (Jan 2017)
(E.O. 13706). 

  

	 	__	 (9) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations
(Jun 2020) (42 U.S.C. 1792). 

  

	 	(d)	 Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph
(d) if this contract was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR 2.101, on the date of award of this contract, and does not contain the clause at 52.215-2, Audit and Records-Negotiation. 

  

	 	(1)	 The Comptroller General of the United States, or an authorized representative of the Comptroller General, shall
have access to and right to examine any of the Contractor’s directly pertinent records involving transactions related to this contract. 

  

	 	(2)	 The Contractor shall make available at its offices at all reasonable times the records, materials, and other
evidence for examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is
completely or partially terminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination settlement. Records relating to appeals under the disputes clause or to litigation or the
settlement of claims arising under or relating to this contract shall be made available until such appeals, litigation, or claims are finally resolved. 

  

	 	(3)	 As used in this clause, records include books, documents, accounting procedures and practices, and other data,
regardless of type and regardless of form. This does not require the Contractor to create or maintain any record that the Contractor does not maintain in the ordinary course of business or pursuant to a provision of law. 

 

	 	(e)(1)	 Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c), and (d) of this clause, the
Contractor is not required to flow down any FAR clause, other than those in this paragraph (e)(1) in a subcontract for commercial items. Unless otherwise indicated below, the extent of the flow down shall be as required by the clause-

  

	 	(i)	 52.203-13, Contractor Code of Business Ethics and Conduct (JUN
2020) (41 U.S.C. 3509). 

  

	 	(ii)	 52.203-19, Prohibition on Requiring Certain Internal
Confidentiality Agreements or Statements (Jan 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in
subsequent appropriations acts (and as extended in continuing resolutions)). 

  

			
	Contract No. 75N92020C00010	  	Page 19

	 	(iii)	 52.204-23, Prohibition on Contracting for Hardware, Software,
and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (JUL 2018) (Section 1634 of Pub. L. 115-91). 

 

	 	(iv)	 52.204-25, Prohibition on Contracting for Certain
Telecommunications and Video Surveillance Services or Equipment. (AUG 2019) (Section 889(a)(1)(A) of Pub. L. 115-232). 

 

	 	(v)	 52.219-8, Utilization of Small Business Concerns (OCT 2018) (15
U.S.C. 637(d)(2) and (3)), in all subcontracts that offer further subcontracting opportunities. If the subcontract (except subcontracts to small business concerns) exceeds the applicable threshold specified in FAR 19.702(a) on the date of
subcontract award, the subcontractor must include 52.219-8 in lower tier subcontracts that offer subcontracting opportunities. 

 

	 	(vi)	 52.222-21, Prohibition of Segregated Facilities (APR 2015).

  

	 	(vii)	 52.222-26, Equal Opportunity (SEP 2015)
(E.O.11246). 

  

	 	(viii)	 52.222-35, Equal Opportunity for Veterans (JUN
2020) (38 U.S.C. 4212). 

  

	 	(ix)	 52.222-36, Equal Opportunity for Workers with Disabilities
(JUN 2020) (29 U.S.C. 793). 

  

	 	(x)	 52.222-37, Employment Reports on Veterans (JUN
2020) (38 U.S.C. 4212). 

  

	 	(xi)	 52.222-40, Notification of Employee Rights Under the National
Labor Relations Act (DEC 2010) (E.O. 13496). Flow down required in accordance with paragraph (f) of FAR clause 52.222-40. 

 

	 	(xii)	 52.222-41, Service Contract Labor Standards (Aug2018) (41 U.S.C.
chapter 67). 

  

	 	(xiii)	 (A) 52.222-50, Combating Trafficking in Persons
(JAN 2019) (22 U.S.C. chapter 78 and E.O 13627). 

  

	 	(B)	 Alternate I (Mar2015) of 52.222-50 (22 U.S.C. chapter 78 and
E.O. 13627). 

  

	 	(xiv)	 52.222-51, Exemption from Application of the Service Contract
Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May 2014) (41 U.S.C. chapter 67). 

  

	 	(xv)	 52.222-53, Exemption from Application of the Service Contract
Labor Standards to Contracts for Certain Services-Requirements (MAY 2014) (41 U.S.C. chapter 67). 

  

	 	(xvi)	 52.222-54, Employment Eligibility Verification
(OCT 2015) (E.O. 12989). 

  

	 	(xvii)	 52.222-55, Minimum Wages Under Executive Order 13658 (DEC 2015).

  

	 	(xviii)	 52.222-62, Paid Sick Leave Under Executive Order 13706 (JAN
2017) (E.O. 13706). 

  

	 	(xix)	 (A) 52.224-3, Privacy Training (Jan 2017) (5 U.S.C. 552a).

  

	 	(B)	 Alternate I (Jan 2017) of 52.224-3. 

 

	 	(xx)	 52.225-26, Contractors Performing Private Security Functions Outside
the United States (Oct 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. 2302 Note). 

  

	 	(xxi)	 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations
(Jun 2020) (42 U.S.C. 1792). Flow down required in accordance with paragraph (e) of FAR clause 52.226-6. 

  

	 	(xxii)	 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels
(Feb 2006) (46 U.S.C. Appx. 1241(b) and 10 U.S.C. 2631). Flow down required in accordance with paragraph (d) of FAR clause 52.247-64. 

 

	 	(2)	 While not required, the Contractor may include in its subcontracts for commercial items a minimal number of
additional clauses necessary to satisfy its contractual obligations. 

 (End of clause) 

  

			
	Contract No. 75N92020C00010	  	Page 20

 PART III. - LIST OF DOCUMENTS AND OTHER ATTACHMENTS 

SECTION J - LIST OF ATTACHMENTS 
  

	 	1.	 Statement of Objectives (SOO) 

 

	 	2.	 Performance Work Statement (PWS) 

 

	 	3.	 Schedule of Deliverables, Payment Schedule 

 

	 	4.	 Quality Assurance Surveillance Plan (QASP) 

  

			
	Contract No. 75N92020C00010	  	Page 21

 Attachment 1 – Statement of Objectives 

 

 Statement of Objectives 

 
 Program Title: Rapid Acceleration of
Diagnostics (RADx) – Tech 
 Project Title: Highly Scalable
SARS-CoV-2 RNA Detection in Minutes (Talis Biomedical Corporation)  

Agency: National Institute of Biomedical Imaging and Bioengineering (NIBIB) / National Institutes of Health (NIH) 

 

	1.	 Background 

 
 The National Institute of Biomedical Imaging and
Bioengineering (NIBIB) has an open solicitation for proposals to provide up to $500 million across multiple projects to rapidly produce innovative SARS-CoV-2
diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon
as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American. 

 

	2.	 Purpose and Objectives 

 
 NIBIB is providing substantial support to
accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests,
that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development
including commercialization and product distribution. The ultimate goal of the RADx program – across multiple projects/contracts – is to make millions of tests per week available to the American public, particularly those most vulnerable
to and/or disproportionately impacted by COVID-19, in the late summer of 2020, and having even more tests available in time for the 2020–2021 flu season. 

To meet the accelerated timelines, RADx has assembled a national network of expert technical, clinical, manufacturing, and regulatory advisors who will
provide individualized assistance for project development and commercialization. Funding for projects selected for this program will be dependent on successfully meeting aggressive project milestones. NIBIB will provide financial and in-kind support to accelerate the entire product life-cycle, from design to market, for projects that meet milestones successfully. To ensure that innovations are available to the public as quickly as possible, NIH
will leverage established partnerships with federal agencies, such as FDA, CDC, CMS, ASPR/BARDA, the Department of Defense, as well as commercial and private entities to propel technologies developed by RADx into widespread use. 

The RADx program will consider innovations at all stages of readiness to circumvent current limitations to SARS-CoV-2 testing capacity, including: 
  

	 	–	 Early stage: transformative innovations based on novel testing strategies that have potential for major scale
up 

  

	 	–	 Mid stage: technologies using novel testing strategies that have demonstrated capability but need further
validation, regulatory approval, and scale up 

  

	 	–	 Advanced stage (RADx ATP): modification and optimization of existing SARS-CoV-2 testing approaches, including clinical laboratory tests, that can dramatically increase testing capacity. Note: This arm of the RADx program is addressed under a separate Acquisition Plan.

  
 Page 1 of 3 

 Attachment 1 – Statement of Objectives 

 

 Design features might include technical innovations that: 

 

	 	–	 Improve analytical performance, e.g., sensitivity, specificity, dynamic range, limit of detection, reliability,
accuracy, speed (time to test result) and throughput 

  

	 	–	 Enhance operational performance through, e.g., development of a patient- and user-friendly design, use of
alternative sampling strategies (e.g., saliva, exhaled breath), integration with mobile-devices, designs for home-based use or strategies to overcome bottlenecks with current testing approaches 

 

	 	–	 Improve access and reduce the cost of testing. 

 

	3.	 Scope 

 
 RADx-Tech is a two phase program. All applications
undergo an intensive week-long risk assessment by a panel of expert technical, clinical, manufacturing, and regulatory advisors. If the proposed technology meets viability metrics, projects may be selected to enter phase one. 

Phase one, performed under a separate funding mechanism, consists of an accelerated research and development program in which the awardee receives both
financial support and in-kind services through RADx grant funding. This outcome of this work is a fully instantiated technology ready for clinical validation, regulatory authorization, production and
commercialization. 
 Phase two, or Work Package 2, of the program, executed under this contract, includes completing the validation, approval, and
production processes in order to deliver a viable product in a scaled up capacity to the U.S. public. 
  

	4.	 Performance Objectives (Required Results) 

 
  

	A.	 Contract recipients have completed major research and development efforts and are focused in phase two on
completion of required clinical validation, preparation of regulatory submissions, scale-up of production capabilities, and preparation for full commercialization of their product – a testing technology.
Every contract will encompass similar expectations and milestones concerned with: 

  

	 	1.	 meeting regulatory requirements, resulting in regulatory authorization for sale and use of the test;

  

	 	2.	 instantiation of agreed-upon production capacity; 

 

	 	3.	 meeting agreed-upon production goals; and 

 

	 	4.	 implementation of an agreed-upon commercial strategy to bring the test to market in a timeframe that will
impact the COVID-19 pandemic as soon as possible. 

  

	B.	 Contract funding in phase two is structured in order to reduce risk to the Government, and is dependent on
achievement of specific milestones in the Schedule of Deliverables, according to the Payment Schedule. 

  

	C.	 The contractor must use a
SARS-Cov-2 test with FDA Emergency Use Authorization (EUA) (or will have EUA near the time of award), indicating a combination of sensitivity, specificity, and usability
appropriate to the intended use according to FDA and/or CDC guidance, as applicable. 

  

	D.	 The contractor must make the product available for independent regulatory/validation assessment. The
independent assessor will be selected by the Government. 

  
 Page 2 of 3 

 Attachment 1 – Statement of Objectives 

 

	5.	 Contract Type 

 
 The contract type is Firm Fixed Price. 

 

	6.	 Place of Performance 

 
 The place of performance will be at the
contractor’s site. 
  

	7.	 Period of Performance 

 
 The period of performance of the contract is
anticipated to be July 30, 2020 through July 29, 2021. 
  

	8.	 Deliverables/Delivery Schedule 

 
 See the attached Schedule of Deliverables. 

 

	9.	 Other Requirements 

 
  

	A.	 The contractor must meet regularly (at least weekly) with NIH officials to update on progress toward
deliverables; anticipated and ongoing issues and problems; and timelines for deliverable completion. When guided by NIH officials, the contractor must be willing to collaborate and cooperate with external organizations as needed to meet the contract
goals in a manner which will not infringe contractor commercial or intellectual property rights. 

  

	10.	 Appendices 

 
 Appendix 1 – Schedule of Deliverables 

  
 Page 3 of 3 

 Performance Work Statement (PWS) 

Title: RADx-Tech: Highly Scalable SARS-CoV-2 RNA Detection in Minutes (Talis
Biomedical Corporation) 
  
  

	1.0	 Background Information 

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has an open solicitation for proposals to provide up to
$500 million across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities.
Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology
Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold
above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American. 
 The
Talis One point-of-care diagnostic platform provides (i) a universal shelf-stable cartridge that fully integrates a rapid NAAT with integrated sample preparation,
(ii) an instrument designed for CLIA waiver to be operated by an untrained user and (iii) cellular connectivity to communicate test results to a central “cloud” database that can be remotely and securely interrogated to obtain
key data required to collect, screen, collate, report, and monitor disease infection and pandemic spread on a micro and macro level. The cartridge design centers around a patented rotary valve that integrates sample purification and is easily
adaptable to alternate workflows and incorporates patented assay wells that combine a fluidic design for minimizing bubbles, visualization of the assay through optically clear regent plugs and a heat-seal for amplicon containment. After insertion of
the cartridge, the instrument confirms the operability of the cartridge, runs the assay and communicates the test result both to the instrument display and to a central database without further intervention. The ease of use, compact size, and speed
enable near-patient diagnosis in primary care, urgent care and other front-line locations during a public health crisis. Finally, the cellular connectivity built into the Talis One platform enables HIPAA compliant transmission, storage, review, and
printing of results. Such centralized storage could permit (i) creation of a public health interface granting access to select information to governmental entities and/or (ii) automatic transmission of “reportable infections,”
such as Covid-19, to public health authorities. 
  

	2.0	 Objectives 

NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution. The ultimate
goal of the RADx program – across multiple projects/contracts – is to make millions of tests per week available to the American public, particularly those most vulnerable to and/or disproportionately impacted by COVID-19, in the late summer of 2020, and having even more tests available in time for the 2020–2021 flu season. 

To meet the accelerated timelines, RADx has assembled a national network of expert technical, clinical, manufacturing, and regulatory advisors
who will provide individualized assistance for project development and commercialization. Funding for projects selected for this program will be dependent on successfully meeting aggressive project milestones. NIBIB will provide financial and in-kind support to accelerate the entire product life-cycle, from design to market, for projects that 

  

	
	Page 1

 
meet milestones successfully. To ensure that innovations are available to the public as quickly as possible, NIH will leverage established partnerships with federal agencies, such as FDA, CDC,
CMS, ASPR/BARDA, the Department of Defense, as well as commercial and private entities to propel technologies developed by RADx into widespread use. 

The RADx program will consider innovations at all stages of readiness to circumvent current limitations to SARS-CoV-2 testing capacity, including: 
  

	 	–	 Early stage: transformative innovations based on novel testing strategies that have potential for major scale
up; 

  

	 	–	 Mid stage: technologies using novel testing strategies that have demonstrated capability but need further
validation, regulatory approval, and scale up; 

  

	 	–	 Advanced stage (RADx ATP): modification and optimization of existing SARS-CoV-2 testing approaches, including clinical laboratory tests, that can dramatically increase testing capacity. 

Design features might include technical innovations that: 
  

	 	–	 Improve analytical performance, e.g., sensitivity, specificity, dynamic range, limit of detection, reliability,
accuracy, speed (time to test result) and throughput; 

  

	 	–	 Enhance operational performance through, e.g., development of a patient- and user-friendly design, use of
alternative sampling strategies (e.g., saliva, exhaled breath), integration with mobile-devices, designs for home-based use or strategies to overcome bottlenecks with current testing approaches; 

 

	 	–	 Improve access and reduce the cost of testing. 

The specific objectives of the Talis project include: 
  

	 	–	 [***]; 

  

	 	–	 [***]; 

  

	 	–	 [***]; 

  

	 	–	 [***]; 

  

	 	–	 [***]; 

  

	 	–	 [***]; 

  

	 	–	 [***] 

  

	3.0	 Scope 

RADx-Tech is a two-phase program. All applications undergo an intensive week-long risk assessment by a
panel of expert technical, clinical, manufacturing, and regulatory advisors. If the proposed technology meets viability metrics, projects may be selected to enter phase one. 

Phase one, performed under a separate funding mechanism, consists of an accelerated research and development program in which the awardee
receives both financial support and in-kind services through RADx grant funding. This outcome of this work is a fully instantiated technology ready for clinical validation, regulatory authorization, production
and commercialization. 

  

	
	Page 2

 Phase two, or Work Package 2, of the program, executed under this contract, includes
completing the validation, approval, and production processes in order to deliver a viable product in a scaled-up capacity to the U.S. public. 

During Work Package 2, Talis will complete verification and validation of its IVD platform, seek Emergency Use Authorization from the FDA for
its COVID-19 assay, manufacture at least 3,300 instruments for sale, and design and construct three automated manufacturing lines, which combined have a total capacity of approximately 1 million
cartridges per month. 
  

	4.0	 Tasks 

Talis shall perform the following tasks: 
  

			
	 #
	  	 PWS TASK

	 4.1
	  	[***]
	     4.1.1
	  	        –    [***]
	     4.1.2
	  	        –    [***]
	     4.1.3
	  	        –    [***]
	     4.1.4
	  	        –    [***]
	     4.1.5
	  	        –    [***]
	 4.2
	  	[***]
	     4.2.1
	  	        –    [***]
	     4.2.2
	  	        –    [***]
	     4.2.3
	  	        –    [***]
	     4.2.4
	  	        –    [***]
	 4.3
	  	[***]
	     4.3.1
	  	        –    [***]
	     4.3.2
	  	        –    [***]
	     4.3.3
	  	        –    [***]

  

	5.0	 Deliverables 

See Attachment #3 of the contract for the Schedule of Deliverables. 

  

	
	Page 3

	6.0	 Quality Assurance 

The Contractor shall ensure that all deliverables are reviewed and edited to ensure that documents are free of typographical, grammatical and
technical errors. The Contracting Officer’s Representative (COR), shall have final authority over the format, style, editing and content of all deliverables. Further, the contractor will be responsible for ensuring that final documents
incorporate all comments, modifications, and editing recommended by the COR. 
  

	7.0	 Quality Assurance Surveillance Plan (QASP) 

See Attachment #4 of the contract, Quality Assurance Surveillance Plan (QASP), for additional information. 

 

	8.0	 Period of Performance 

The period of performance of the contract is July 30, 2020 through July 29, 2021. 

  

	
	Page 4

 SCHEDULE OF DELIVERABLES 

 

													
	 No.
	  	 Objective Defined
	  	 Milestone Defined
	  	 Deliverable
	  	 Success Criteria
	  	 Deliverable

Due Date
	  	 Stage

	1	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	1
	2	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	1
	3	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	2
	4	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	2
	5	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	2
	6	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	3
	7	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	3
	8	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	3
	9	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	4
	10	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	4
	11	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	4
	12	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	5
	13	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	5
	14	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	1-5
	15	  	[***]	  	[***]	  	[***]	  	[***]	  	[***]	  	1-5

  

	
	Page 1

 PAYMENT SCHEDULE 

 

							
	 Stage
	  	 Title
	  	Completion Date	 	Firm Fixed Price
	 1
	  	[***]	  	[***]	 	[***]
	 2
	  	[***]	  	[***]	 	[***]
	 3
	  	[***]	  	[***]	 	[***]
	 4
	  	[***]	  	[***]	 	[***]
	 5
	  	[***]	  	[***]	 	[***]
	 Total FFP Amount
	  		  		 	$ 25,400,000

  

	
	Page 2

 QUALITY ASSURANCE SURVEILLANCE PLAN 

(QASP) 
  

	1	 INTRODUCTION 

This quality assurance surveillance plan (QASP) is pursuant to the milestone deliverables attached to the Performance Work Statement (PWS) entitled [***]. This
plan sets forth the procedures and guidelines the RADx-Tech Contracting Officers and Contracting Officer’s Representatives (CORs) will use in ensuring the required performance standards or service levels are achieved by the contractor. 

 

	1.1	 Purpose 

1.1.1 The purpose of the QASP is to describe the systematic methods used to monitor performance and to identify the required documentation and the resources to
be employed. The QASP provides a means for evaluating whether the contractor is meeting the performance standards/quality levels identified in the PWS and the contractor’s quality control plan (QCP), and to ensure that the government pays only
for the level of services received. 
 1.1.2 This QASP defines the roles and responsibilities of all members of the integrated project team (IPT), identifies
the performance objectives, defines the methodologies used to monitor and evaluate the contractor’s performance, describes quality assurance documentation requirements, and describes the analysis of quality assurance monitoring results. 

 

	1.2	 Performance Management Approach 

1.2.1 The PWS structures the acquisition around “what” service or quality level is required, as opposed to “how” the contractor should
perform the work (i.e., results, not compliance). This QASP will define the performance management approach taken by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to monitor and manage the contractor’s performance to
ensure the expected outcomes or performance objectives communicated in the PWS are achieved. Performance management rests on developing a capability to review and analyze information generated through performance assessment. The ability to make
decisions based on the analysis of performance data is the cornerstone of performance management; this analysis yields information that indicates whether expected outcomes for the project are being achieved by the contractor. 

1.2.2 Performance management represents a significant shift from the more traditional quality assurance (QA) concepts in several ways. Performance management
focuses on assessing whether outcomes are being achieved and to what extent. This approach migrates away from scrutiny of compliance with the processes and practices used to achieve the outcome. A performance-based approach enables the contractor to
play a large role in how the work is performed, as long as the proposed processes are within the stated constraints. The only exceptions to process reviews are those required by law (federal, state, and local) and compelling business situations,
such as safety and health. A “results” focus provides the contractor flexibility to continuously improve and innovate over the course of the contract as long as the critical outcomes expected are being achieved and/or the desired
performance levels are being met. 
  

	1.3	 Performance Management Strategy 

1.3.1 The contractor is responsible for the quality of all work performed. The contractor measures that quality through the contractor’s own quality
control (QC) program. QC is work output, not workers, and 

  
 1 

 
therefore includes all work performed under this contract regardless of whether the work is performed by contractor employees or by subcontractors. The contractor’s QCP will set forth the
staffing and procedures for self-inspecting the quality, timeliness, responsiveness, customer satisfaction, and other performance requirements in the PWS. The contractor will develop and implement a performance management system with processes to
assess and report its performance to the designated government representative. The contractor’s QCP will set forth the staffing and procedures for self-inspecting the quality, timeliness, responsiveness, customer satisfaction, and other
performance requirements in the PWS. This QASP enables the government to take advantage of the contractor’s QC program. 
 1.3.2 The government
representatives will monitor performance and review performance reports/milestone deliverables furnished by the contractor. If a milestone deliverable is delayed, the contractor will be responsible for reporting the reason and providing an updated
schedule. 
  

	2	 ROLES AND RESPONSIBILITIES 

 

	2.1	 The Contracting Officer 

The Contracting Officer (CO) is responsible for monitoring contract compliance, contract administration, and cost control and for resolving any differences
between the observations documented by the Contracting Officer’s Representative (COR). The CO will designate one full-time COR as the government authority for performance management. The number of additional representatives serving as technical
inspectors depends on the complexity of the services measured, as well as the contractor’s performance, and must be identified and designated by the CO. 
  

	2.2	 The Contracting Officer’s Representative 

The Contracting Officer’s Representative (COR) is designated in writing by the CO to act as his or her authorized representative to assist in
administering a contract. COR limitations are contained in the written appointment letter. The COR is responsible for technical administration of the project and ensures proper government surveillance of the contractor’s performance. The COR is
not empowered to make any contractual commitments or to authorize any contractual changes on the government’s behalf. Any changes that the contractor deems may affect contract price, terms, or conditions shall be referred to the CO for action.
The COR will have the responsibility for completing QA monitoring forms used to document the inspection and evaluation of the contractor’s work performance. Government surveillance may occur under the inspection of services clause for any
service relating to the contract. 
  

	3	 IDENTIFICATION OF REQUIRED PERFORMANCE STANDARDS/QUALITY LEVELS 

The required milestone deliverables are included in the PWS. If the contractor meets the milestone deliverable, it will be paid the representative milestone
payment agreed on in the contract. If the contractor does not meet the milestone deliverable, the milestone payment will be delayed, and it will put the future milestone payments at risk. 

 

	4	 METHODOLOGIES TO MONITOR PERFORMANCE 

 

	4.1	 Surveillance Techniques 

In an effort to minimize the performance management burden, simplified surveillance methods shall be used by the government to evaluate contractor performance
when appropriate. The primary methods of surveillance are: 

  
 2 

	 	•	 	 100% Inspection – As determined appropriate, the COR shall review the generated documentation and enter
summary results into the Surveillance Activity Checklist. 

  

	4.2	 Acceptable Performance Levels 

Milestone payments will be issued upon meeting milestone deliverables. 
  

	5	 QUALITY ASSURANCE DOCUMENTATION 

 

	5.1	 Monitoring Form 

The government’s QA surveillance, accomplished by the COR, will be reported using the monitoring form in Attachment 2. The form will document the
government’s assessment of the contractor’s performance under the contract to ensure that the required results are being achieved. 
 5.1.1 The COR
and CO will retain a copy of all completed QA surveillance forms. 
  

	6	 ANALYSIS OF QUALITY ASSURANCE ASSESSMENT 

 

	6.1	 Determining Performance 

6.1.1 Government shall use the monitoring methods cited to determine whether the milestone deliverables have been met. If the contractor has not met milestone
deliverable , it may be asked to develop a corrective action plan to show how and by what date it intends to meet the milestone deliverable. Failure to meet the milestone deliverable may result in a delay of the milestone payment and may put future
milestone payments at risk. 
  

	6.2	 Reporting 

6.2.1 At the end of each contract month, the COR will prepare a written report summarizing the overall results of the quality assurance surveillance of the
contractor’s performance. This written report will become part of the QA documentation. It will enable the government to demonstrate whether the contractor is meeting the stated objectives. 

 

	6.3	 Reviews and Resolution 

6.3.1 The COR may require the contractor’s project manager, or a designated alternate, to meet with the CO and other government IPT personnel as deemed
necessary to discuss performance evaluation. The COR will define a frequency of in-depth reviews with the contractor, including appropriate self-assessments by the contractor; however, if the need arises, the
contractor will meet with the COR as often as required or per the contractor’s request. The agenda of the reviews may include: 
  

	 	•	 	 Weekly performance assessment data and trend analysis; Issues and concerns of both parties;

  

	 	•	 	 Projected outlook for upcoming months and progress against expected trends, including a corrective action plan
analysis; 

  

	 	•	 	 Recommendations for improved efficiency and/or effectiveness; 

 

	 	•	 	 Issues arising from the performance monitoring processes. 

  
 3 

 The COR and the CO must coordinate and communicate with the contractor to resolve issues and concerns
regarding marginal or unacceptable performance. 
 ATTACHMENT 1: PERFORMANCE REQUIREMENTS SUMMARY 

See Schedule of Deliverables for details regarding performance requirements. 

  
 4 

 ATTACHMENT 2: Deliverable Acceptance Form 

 

			
	Deliverable Name	 	
		
	Acceptance Criteria	 	
		
	Verification Method	 	
		
	Validation Method	 	
		
	 Contracting Officer’s Representative

(COR) Name
	 	
		
	COR Signature / Date	 	

  
 5 

 

 

 

 

 MODIFICATION OF CONTRACT CONTINUATION PAGE 

Contract No. 75N92020C00010 
 Modification 2 

 
  

BEGINNING WITH THE EFFECTIVE DATE OF THIS MODIFICATION, THE GOVERNMENT AND THE CONTRACTOR MUTUALLY AGREE AS FOLLOWS: 

Section B.3., Advance Understandings, is revised to add the following by full text: 

Health Resources Priorities and Allocations System (HRPAS) priority rating of DO-HRPAS is added to this
contract as follows: 
 This is a DO rated order for the purpose of emergency preparedness and the Contractor shall follow all the provisions
of the Health Resources Priorities and Allocations System regulation (45 CFR Part101). If the contractor needs to utilize industrial resources to fulfill this rated order for a health resource, it is authorized pursuant to 45 CFR §101.36(b) to
place the same priority rating and program identification symbol for health resources on its orders for industrial resources with its suppliers. 

Section G.2., Contracting Officer’s Representative, is revised as follows: 

The following Contracting Officer’s Representative (COR) will represent the Government for the purpose of this contract: 

Colleen Sico 
 Phone: [***] 

Email: [***] 
 Section I.2., Additional FAR
contract clauses included in full text, is revised to include the following: 
 FAR 52.211-15,
Defense Priority and Allocation Requirements, is added: 
 This is a rated order certified for national defense, emergency preparedness, and
energy program use, and the Contractor shall follow all the requirements of the Defense Priorities and Allocations System regulation (15 CFR 700). 

All other terms and conditions of the contract remain the same. 

Page 3 or 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]